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RELATIONSHIPS AMONG PARKINSON’S DISEASE SYMPTOMS, STIGMA, AND 
MENTAL HEALTH: A STRENGTHS-BASED PERSPECTIVE 
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A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2020 
 
Major Director: Paul B. Perrin, Ph.D., Associate Professor of Psychology, Director, Health 
Psychology, Department of Psychology 
 
As rates of Parkinson’s disease (PD) increase, so does the need to examine some of the negative 
social consequences experienced by people with PD. Symptoms of PD have been linked to 
greater experiences of stigma, and the more visible symptoms of PD increase an individual’s 
likelihood for experiencing stigmatization and social rejection. Individuals who experience high 
levels of stigma generally have poorer mental health outcomes. While these relationships are 
well documented, little is known about whether stigma mediates the relationship between PD 
symptoms and mental health outcomes. Additionally, some past research suggests that the 
personal strengths of social support and spirituality may moderate the relationship between 
stigma and mental health in other populations; however, no research has examined the potential 
moderating effects of these variables in individuals with PD. This study sought to examine the 
connections among PD symptoms, stigma, and mental health, as well as examine social support 
and spirituality as potential buffers. This study represents a secondary data analysis of clinical 
data reflecting these constructs collected from 392 individuals with PD being seen at a PD 
specialty clinic affiliated with an academic medical center. Results showed stigma partially 
mediated the relationship between both motor and non-motor symptoms and mental health 
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problems. There was also a moderating effect of social support on the relationships among 
motor/non-motor symptoms, stigma, and mental health problems, with stronger indirect effects at 
low levels of social support, suggesting that this mediational model held only for individuals 
with low social support. Spirituality moderated the relationships among motor/non-motor 
symptoms, stigma, and mental health problems, with stronger indirect effects at lower levels of 
spirituality, again suggesting that this mediational model held only for those with low or mid-
levels of spirituality. Implications of these results are that health professionals working with 
individuals with PD may wish to consider stigma and discrimination in how they present and 
design treatment options for PD patients. Interventions designed to increase and foster social 
support among individuals with PD, such as helping individuals maintain a number of positive 
close relationships, may have beneficial mental health effects. Also, including an assessment of 
spiritual practice and beliefs into patient assessments may help health care providers better 
understand an individual with PD’s worldview, and subsequently view of chronic illness, if there 
is a spiritual community of support, and if spiritual interventions and coping mechanisms may be 
appropriate and helpful for the individual.  
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Chapter 1 
Overview 
This manuscript will begin by discussing the prevalence of Parkinson’s disease (PD). To 
date, the causes of PD are not yet known, and as such there are no definitive diagnostic tests for 
PD. This is followed by a discussion of PD etiology, the progression of the disease, and attempts 
at defining different stages of PD. The clinical presentation of PD can vary by the individual, and 
stages are not always linear. The next section will discuss treatment of PD. Although there are no 
neuroprotective therapies and no cure for PD, there are some pharmacological therapies aimed at 
reducing PD symptoms to improve quality of life. It will be illustrated that individuals with PD 
often experience stigma as a result of the negative social interpretations of the symptomatic 
movements of PD. The Minority Stress Model will be used to illustrate how stigma may account 
in part for the relationship between PD symptoms and negative mental health. This is followed 
by research exploring the protective factors of social support and spirituality for individuals with 
PD from experiences of stigma. The objectives of the current study will be discussed next 
followed by the methods, data analysis plan, and a discussion of the potential implications of the 
results. 
Epidemiology 
A progressive neurodegenerative disease, Parkinson’s disease (PD) over time leads to 
both cognitive impairment (Petrou, Dwamena, Foerster, MacEachern, Bohnen, Müller, et al., 
2015) and physical disability (Shulman et al., 2016). An individual’s independent functioning 
may be limited as a result of these impairments and disabilities. In the United States, PD is the 
second most common progressive neurodegenerative disease (de Lau & Breteler, 2006). PD 
affects approximately 1% of individuals over the age of 60 (Nussbaum & Ellis, 2003), and other 
rates suggest about 1 to 2 individuals per 1,000 (Tysnes & Storstein, 2017). By 2030, an 
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estimated 1.2 million individuals will be living with PD in the US (Marras et al., 2018). The 
increases in number of PD cases is due to both proportions of the older adult population with PD 
increasing and the overall number of older adults in the population increasing (Dorsey & Bloem, 
2018; Marras et al., 2018). PD is an age-related disease, with prevalence increasing with age, and 
onset is rare before the age of 50 (Muangpaisan et al., 2011; Rocca, 2018; Savica et al., 2018). 
While estimates vary, approximately 1% of adults over the age of 60 are affected by PD in 
industrialized countries (Nussbaum & Ellis, 2003), this number increases to approximately 2.6% 
of adults over the age of 85 who are affected (Pringsheim et al., 2014). 
Age is a commonly accepted risk factor for PD (Collier et al., 2017). Other potential risk 
factors include environmental toxins, drugs, pesticides, brain microtrauma, and genetics 
(Cacabelos, 2017). However, there remains conflicting evidence around a number of risk factors 
including gender, ethnicity, living circumstances, and occupations (Ball et al., 2019). All these 
factors have been suspected in heightened PD risk, although the evidence remains conflicted.  
Disease Course and Diagnosis 
 The etiology of PD is still not fully understood, despite ongoing research examining the 
underlying causes. PD represents multi-level system dysfunction with widespread involvement 
of other body systems (Caviness, 2014; Ehgoetz Martens & Lewis, 2017). First, cellular and 
tissue abnormalities occur as a result of genetic influences. As a result of these abnormalities, the 
dopamine neurons in the substantia nigra region of the brain are damaged, altered, or killed 
(Caviness, 2014). The resulting decrease in dopamine plays a critical role in the development of 
the motor symptoms of the disease, and ultimately influences an individual’s behavior (Caviness, 
2014). Genetic mutations are still not able to explain the majority of PD cases, despite the efforts 
to identify these mutations (Caviness, 2014; de Lau & Breteler, 2006). As approximately 90% of 
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PD cases are sporadic (de Lau & Breteler, 2006), there may be other important factors—such as 
exposure to environmental toxins (Ball et al., 2019; Cacabelos, 2017)—which contribute to the 
development of PD. 
 There is not currently a definitive diagnostic test for PD, and as a result PD may be 
difficult to diagnose due to the similarities it shares with other neurological conditions. While 
diagnostic certainty is not possible during an individual’s life (Postuma et al., 2015), postmortem 
confirmation of diagnoses using neuropathological criteria may occur (Adler et al., 2019; Gibb & 
Lees, 1988). Research using postmortem confirmation suggests a diagnostic accuracy which 
ranges between 75-95% (Hughes, Daniel, Kilford, & Lees, 1992; Hughes, Giobbie-Hurder, 
Weaver, Kubal, & Henderson, 1999; Litvan et al., 1998; Tolosa, Wenning, & Poewe, 2006). 
Consequently, a clinical diagnosis of PD is based on the presence of characteristic motor 
symptoms, how the individual responds to L-Dopa, and additional associated inclusionary and 
exclusionary symptoms (Rao et al., 2003). 
 As a progressive condition, there have been many attempts to define and outline the 
stages and progression of PD (Goetz et al., 2004; Owen et al., 1993; Starkstein, Bolduc, Preziosi, 
& Robinson, 1989). One of the mostly commonly used systems was outlined by Hoehn and Yahr 
in which five stages were identified (Hoehn & Yahr, 1967). The first stage generally has 
unilateral involvement and is characterized by minimal to no functional impairment. The second 
stage is defined by bilateral involvement; however, balance is usually not impaired. In the third 
stage, individuals may still be able to take care of themselves, unsteadiness first begins to appear, 
and individuals may not be able to maintain their balance when standing if pushed. PD is 
considered fully developed and severely disabling by stage four. Individuals may still be able to 
stand or walk without assistance at this point. In the fifth stage, individuals are often confined to 
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a bed or wheelchair. It is important to note that progression through these stages may not always 
be linear (Poewe, 2006). One example of this is that there are typically greater declines in motor 
function earlier in the disease than later (Poewe, 2006). 
 PD itself is not usually fatal; rather, individuals with PD often die of complications from 
later stages of the disease and comorbidities (Beyer et al., 2001; Bugalho et al., 2019; Paul et al., 
2019; Wermuth et al., 1995). PD has several different phenotype varieties, all of which are 
progressive (Evans et al., 2011). While clinical presentation varies, early physical symptoms may 
include bradykinesia (slow movements), stiffening muscles, hand tremors, sleep disruption, 
speech changes, and decreased facial expressivity (Jankovic, 2008; Mosley et al., 2017). Along 
with the physical symptoms, both early cognitive and emotional changes may occur such as 
feeling depressed, anxious, or fearful and difficulty concentrating (Weintraub & Burn, 2011). 
The progression of physical symptoms includes loss of muscle control which may lead to 
difficulty swallowing, urinary incontinence, and bowel dysfunction (NINDS, 2019). Patients 
may also experience hallucinations, delusions, and dementia as the disease progresses and during 
pharmacological treatment (Mosley et al., 2017; Weintraub & Burn, 2011). 
 Life expectancy of individuals with PD is thought to be reduced (Elbaz et al., 2003; 
Morens et al., 1996). Individuals with PD will live 15 years post-diagnosis on average (Lees et 
al., 2009). However, due to treatment advances, some individuals with PD are living even longer 
(Lee & Gilbert, 2016). Due to the variation in disease progression, disease course may be greatly 
impacted by age of diagnosis. Studies suggest that individuals who are diagnosed younger tend 
to live longer post-diagnosis than individuals who are diagnosed when they are older (Ishihara et 
al., 2007). 
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Symptoms 
The clinical presentation of PD can vary by patient and is very similar to other 
neurological conditions. Symptoms of PD have been classified by symptom type (e.g., motor 
aspects of experiences of daily living, non-motor experiences of daily living, cognitive 
impairment, depressed/anxious mood, etc.) for both diagnostic and research purposes (Goetz et 
al., 2008; Peto et al., 1998). Motor symptoms, including bradykinesia, postural instability, resting 
tremor (shaking while in a relaxed state), and akinesia (loss or impaired voluntary movement) 
have historically been characteristic of PD (Mandir & Vaughan, 2000). Additional motor 
symptoms may also be present, including reduced facial expression (Ricciardi et al., 2015) and 
gait issues (Forsaa et al., 2015). While motor Parkinsonism remains a prominent feature of the 
disease, the non-motor manifestations of PD have received increased attention. Individuals will 
generally present numerous non-motor symptoms by 10 years post-diagnosis (Poewe, 2006). 
Non-motor symptoms of PD may include cognitive impairment, apathy, depression, anxiety, 
sleep disruption, psychosis, and dementia (Mosley et al., 2017). 
Treatment 
 To date, there is no neuroprotective therapy for PD (AlDakheel et al., 2014) and no cure 
(Connolly & Lang, 2014). There are pharmacological therapies aimed at reducing symptoms to 
improve quality of life. Pharmacological interventions are usually pursued when individuals with 
PD experience impairment or embarrassment from their symptoms (Connolly & Lang, 2014). 
While symptoms are mild, generally in the early stages of the disease, monoamine oxidase type 
B inhibitors (MAOBIs) such as rasagiline or selegiline might be prescribed to reduce symptoms 
(Ives et al., 2004). Additionally, in the early stages of PD and once activities of daily living 
become impaired, dopamine agonists or levodopa (L-dopa) may be effective treatments 
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(Connolly & Lang, 2014; Fox et al., 2011). L-dopa is one of the most common pharmacological 
treatments for PD (Mandir & Vaughan, 2000). 
 Individuals with PD have depleted levels of dopamine in the brain, and the role of L-dopa 
is to raise dopamine levels (Connolly & Lang, 2014). Administration of L-dopa is typically done 
in combination with a decarboxylase inhibitor—carbidopa—which prevents the conversion of L-
dopa to dopamine and helps maximize the delivery to the brain (Mandir & Vaughan, 2000). L-
dopa has been associated with reductions in freezing, somnolence, edema, risk of impulse control 
disorders, and hallucinations compared to dopamine agonists (Ferreira et al., 2013) and is 
considered to be one of the most effective pharmacological treatments currently available for PD 
(Mandir & Vaughan, 2000). 
 As the disease progresses, PD becomes more resistant to treatment, as non-dopaminergic 
brain regions are increasingly affected (Connolly & Lang, 2014). The degenerative processes 
that cause PD are not directly influenced by dopamine treatments (Korczyn & Hassin-Baer, 
2015). Pharmacologic interventions for patients have yet to catch-up or benefit from advances in 
understandings of the genetic contributions, molecular mechanisms, and pathology of PD 
(Suchowersky et al., 2006). Additionally, while PD symptoms may be decreased using dopamine 
agonists and L-dopa, there are many potential side effects. Adverse side effects from the 
medications may include dyskinesias (i.e., involuntary muscle movements), nausea, psychosis, 
dopamine dysregulation syndrome, impulsive behaviors (Connolly & Lang, 2014). 
Stigma in PD 
Individuals with PD often experience stigma as a result of the negative social 
interpretations of the symptomatic movements such as rigidity, reduced facial expressions, and 
tremors (Moore & Knowles, 2006). Goffman defined stigma as “the situation of the individual 
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who is disqualified from full social acceptance” (1963, pg. 3). An individual once stigmatized 
becomes discounted and tainted, no longer a whole person (Goffman, 1963). In addition to being 
stigmatized for symptomatic movements of PD, PD symptoms are often mistaken for other 
stigmatized conditions. For example, movement disorders may be misinterpreted as drunkenness, 
or difficulty in speech or communication may be mistaken for an intellectual disability (Moore & 
Knowles, 2006). Greater risk of stigmatization and social rejection occur with more visible PD 
symptoms (Hermanns, 2013). Individuals with PD employ a number of strategies to hide their 
symptoms and avoid stigmatization, by reducing communication or placing their hands in their 
pockets (Burgener & Berger, 2008; Hermanns, 2013). In several studies, both the general public 
and medical professionals across cultures (Taiwan and the US) rated individuals with PD as less 
friendly, happy, and social due to speech production difficulties and facial masking symptoms 
(Hemmesch et al., 2009; Jaywant & Pell, 2010; Tickle-Degnen et al., 2011). Awareness of 
stigmatization and negative interpretations of the PD symptoms by individuals with PD may 
result in isolation and social withdrawal behaviors (Burgener & Berger, 2008). PD stigma has 
been significantly correlated with negative quality of life (Ma et al., 2016). 
Stigmatization of individuals with PD have been directly linked to PD symptoms. These 
symptoms include facial masking (Gunnery et al., 2015; Hemmesch, 2014; Hermanns, 2013), 
dystonias, akinesia (Chapuis et al., 2004), restless leg syndrome (Fereshtehnejad et al., 2015), 
postural instability, bradykinesia, rigidity, and tremors (Lyons et al., 1997). It has been suggested 
that stigma often arises from PD motor symptoms, as these symptoms are viewed by others as 
signs of fragility (Maffoni et al., 2017). Increased rates of depression, anxiety, and negative self-
image have also been linked to experiences of stigma in PD (Hatzenbuehler et al., 2013; Mak et 
al., 2007; Meyer, 2003; Pascoe & Smart Richman, 2009). Previous research in general 
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populations has found strength-based factors, for example coping and resilience, weakened the 
strength of associations between stigma and adverse mental health outcomes (Bockting et al., 
2013; Hatzenbuehler et al., 2013; Meyer, 2003); however, these relationships have not been 
examined in the context of PD. To date, very few studies have examined the psychosocial 
strengths of patients with PD to decrease experiences of stigma, improve mental health 
outcomes, and improve adjustment to the diagnosis. A better understanding of strength-based 
factors and their relationship to stigma may improve quality of life in individuals with PD and 
possibly their daily functioning. 
Mental Health and PD 
 Apathy, anxiety, and depression are extremely common among individuals with PD 
(Kano et al., 2011; Pagonabarraga et al., 2015; Quelhas & Costa, 2009). A formal clinical 
diagnosis of PD may only occur once motor symptoms are present. It was originally thought 
non-motor symptoms (NMS) only occurred in later stages, but it is now known they may be 
manifest at any stage (Kano et al., 2011). Previous research suggests that anxiety may be present 
very early in the disease, a finding which held even when examining medical histories up to 20 
years prior to the first motor symptom (Kano et al., 2011). These mental health issues can be 
exacerbated by stigma experienced as a result of having PD (Oguru et al., 2010). Comorbid 
mental health diagnoses can strongly negatively impact the quality of life of individuals with PD 
and that of their caregivers (Brok et al., 2015; Kano et al., 2011; Quelhas & Costa, 2009). 
 Apathy. Apathy is considered a behavioral syndrome which has behavioral, cognitive, 
and affective features and is defined by decreased motivation, reduced interests or emotions, and 
decreased goal-directed behaviors which cannot be attributed to other cognitive impairment or 
emotional distress (Pagonabarraga et al., 2015). Maintenance of motivation is attributed to 
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subcortical structures, specifically the link between the limbic system and prefrontal cortex. 
Disruption of these networks, as occurs in PD, alters the ability to associate complex stimuli with 
emotions (Pagonabarraga et al., 2015). Apathy is the clinical manifestations of these changes. 
Along with apathy being clinically significant to PD, motivation is an important psychological 
feature to overall mental well-being. Motivation promotes goal-driven behaviors and sustaining 
those goal-directed behaviors (Pagonabarraga et al., 2015). An absence of self-initiated goal-
directed behaviors as seen in apathy is sometimes described as an indifference or flattening of 
affect (Pagonabarraga et al., 2015).  
There is a high prevalence of apathy in PD which can greatly influence the quality of life 
of both individuals with PD and their caregivers (Pagonabarraga et al., 2015). Apathy is seen in 
approximately 20-36% of newly diagnosed individuals, with a decrease among those 
subsequently treated with dopaminergic treatments (Pagonabarraga et al., 2015). The prevalence 
of apathy is higher among PD patients with dementia (60% vs 40%, 5-10 years post diagnosis) 
(Pagonabarraga et al., 2015). A meta-analysis found an overall prevalence of about 40%, with 
apathy present without depression or cognitive impairment in half of cases (Brok et al., 2015). 
Apathy was also associated with more severe disability, older age, increased motor symptoms, 
depression, worse cognitive function, and potentially lower quality of life and increased 
caregiver burden (Brok et al., 2015). Previous research has also shown that apathy is strongly 
associated with stigma and cognitive symptoms (Oguru et al., 2010). 
Apathy is frequently seen in PD, as a unique symptom or syndrome independent of 
depression—although it is conventionally considered a clinical symptom of depression. A review 
of apathy found three possible explanations for apathy in PD (Bogart, 2011). First, research has 
suggested links among dopamine depletion and basal ganglia dysfunction in PD and apathy—an 
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endogenous explanation. Second, activity restriction and disability from PD may lead to 
apathy—an exogenous explanation. Finally, methodological confounds and conceptual problems 
may be obscuring the relationship between apathy and PD (Bogart, 2011). However, as one of 
the most debilitating and common non-motor manifestations of PD (Martínez-Horta et al., 2014; 
Starkstein, 2012), for the purposes of this study, apathy will be included as a mental health 
outcome given its potential to add a heavy burden for the individual with PD and potential to 
operate differently than either depression or anxiety.  
Anxiety. In PD, the most common anxiety disorders include panic disorder, phobic 
disorder, social phobia, and generalized anxiety disorder (Kano et al., 2011; Pontone et al., 2009; 
Walsh & Bennett, 2001). Anxiety is characterized by worry, fear, and apprehension (Kano et al., 
2011). Clinically significant anxiety prevalence is estimated in between 25% to 40% of 
individuals with PD (Kano et al., 2011; Pontone et al., 2009; Quelhas & Costa, 2009; Starkstein, 
Robinson, Leiguarda, & Preziosi, 1993; Walsh & Bennett, 2001). It has been posited that anxiety 
may be a response to the PD symptoms (Walsh & Bennett, 2001). There are several factors 
which may perpetuate anxiety throughout the disease course, including worrying about the risk 
of falls and disturbances in balances and unexpected fluctuations in symptoms, as well as social 
anxiety, a fear of negative evaluation in public (Walsh & Bennett, 2001). For example, 
individuals may become self-conscious or embarrassed by their motor impairments such as their 
stooped posture, shuffling gait, and tremor (Quelhas & Costa, 2009). This negative evaluation 
may also be stigmatization, the consequences of which may include anxiety and social 
withdrawal. Anxiety has been significantly associated with decreased quality of life among 
individuals with PD, perhaps even more so than depression (Kano et al., 2011; Pontone et al., 
2009; Quelhas & Costa, 2009). 
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Depression. Clinical depression includes consistent symptoms for at least a two week 
period in which an individual has a depressed mood, loss of interest or pleasure in daily 
activities, fatigue, weight loss, and insomnia (Kano et al., 2011). The prevalence of depression is 
estimated between 4% to 70%, although common ranges are between 30-45% of individuals with 
PD will experience clinically significant depression (Quelhas & Costa, 2009). Variation in 
estimates may be the result of how depression is being measured and the specific PD population 
being surveyed. Previous studies have correlated depression with duration of illness, severity of 
impairments, and cognitive deficits (Starkstein et al., 1993). Research suggests that depression is 
a main factor related to negative quality of life for individuals with PD (Quelhas & Costa, 2009). 
Strength-Based Factors 
There has been limited research with individuals with PD exploring the strength-based, 
protective factors of social support and spirituality. However, research in both general and PD 
populations has demonstrated that social support and spirituality may protect against a variety of 
mental health problems (Brod et al., 1998; Reynolds, 2017), stigma, and decreased quality of life 
(Reynolds, 2017; Schrag et al., 2003).  
Social Support. Social support is not well understood for individuals with PD, and is 
most often studied in conjunction with depression (Schreurs et al., 2000). Studies of social 
support for individuals with PD generally examine one’s perceptions of support from others, 
such as support from family and friends or difficulties in close relationships (Peto et al., 1995, 
1998). However, for both PD and other chronic illnesses, some studies have shown that social 
support from close relationships does not differ as a function of disease severity (Fitzpatrick, 
Peto, Jenkinson, Greenhall, & Hyman, 1997; Fitzpatrick, Newman, Lamb, & Shipley, 1988). 
Individuals with PD who are less satisfied with their social relationships and experience lower 
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social support are more likely to experience higher rates of anxiety, depression, stress, and 
decreased quality of life (Brod et al., 1998; Fleminger, 1991; Simpson et al., 2006; Takahashi et 
al., 2016). Social support has also been associated with positive well-being (e.g., happiness), 
suggesting that it is not just psychological distress but well-being that may be influenced by 
social support (MacCarthy & Brown, 1989). A study by Schrag and colleagues (2003) compared 
age of PD onset, and individuals with younger onset PD experienced greater disruption of their 
family and social lives and higher rates of perceived stigmatization. 
Spirituality. Spirituality has been identified in extant literature as a form of coping with 
chronic illness (Reynolds, 2017), which includes individuals with PD. Research has 
demonstrated that individuals with a spiritual life and/or committed religious orientation tend to 
have lower rates of depression and anxiety, better ability to cope, and greater overall quality of 
life (Harris et al., 2010; Reynolds, 2017; Rowe & Allen, 2004; Shafranske & Malony, 1990; 
Unantenne et al., 2013). However, the research focused on spiritual coping for PD is extremely 
limited. Spirituality often refers to purpose, meaning, transcendence, connectedness, or direction, 
although a precise and universal definition is not agreed upon (Reynolds, 2017). Spiritual coping 
for individuals with PD may include using spirituality to cope with their disease, accepting and 
adjusting to their diagnosis, and maintaining hope (Soundy et al., 2014). For some, the ritual of 
prayer is also utilized for healing, managing the disease, and in making decisions (Soundy et al., 
2014). In a qualitative study of 56 PD patients, five themes related to spiritual coping emerged: 
(1) feeling a sense of gratitude; (2) connecting with individuals; (3) depending on faith; (4) 
providing meaning to PD; and (5) prayer (Reynolds, 2017). Using spirituality for coping is not 
just limited to living with a chronic illness, but can also assist with other health-related 
challenges including apathy, anxiety, depression, and stigma (Hermanns, 2013; Reynolds, 2017). 
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Theoretical Model 
A very common theoretical framework for explaining stigma and health risks is the 
Minority Stress Model (Meyer, 2003). This framework was developed to explain sexual minority 
health disparities through their experiences of chronic stress, hostility, harassment, victimization, 
and discrimination (Meyer, 2003). In other words, the chronic, unique, and socially based 
stressors faced by sexual minorities related to their identities will negatively impact their mental 
health (Meyer, 2003). This model includes a variety of stressors and coping mechanisms and the 
resulting mental health outcomes (Meyer, 2003). While this framework was originally developed 
and validated in a sexual minority adult population, it has been adapted for a variety of minority 
populations (Meyer et al., 2008) including individuals with general disabilities (Conover & 
Israel, 2019). 
The Minority Stress Model can be used to assess a variety of relationships related to the 
experiences of individuals with PD. Symptoms of PD lead to individuals with PD experiencing 
stigma and discrimination (Moore & Knowles, 2006). Individuals with PD also experience high 
rates of apathy, anxiety, and depression (Kano et al., 2011; Pagonabarraga et al., 2015; Quelhas 
& Costa, 2009). Previous research in other populations has documented that experiences of 
discrimination are predictive of higher levels of mental health issues (Burgener & Berger, 2008; 
Maffoni et al., 2017; Sutter & Perrin, 2016). Additionally, there is some evidence that social 
support and spirituality may be able to mitigate the link between discrimination and mental 
health, although these effects have not been documented in people with disabilities (Brewster et 
al., 2016; Ojeda & Piña-Watson, 2013). 
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The Current Study 
 As the prevalence of PD increases, so does the need to examine some of the negative 
social consequences. Previous literature has linked symptoms of PD to increased experiences of 
stigma (Moore & Knowles, 2006). Experiences of stigma may result in PD patients withdrawing 
socially and isolating themselves (Burgener & Berger, 2008), which ultimately may lead to 
poorer mental health outcomes (Hatzenbuehler et al., 2013; Mak et al., 2007; Meyer, 2003; 
Pascoe & Smart Richman, 2009). Despite the clear correlations among symptoms, stigma, and 
mental health problems, there is relatively little research examining the potential mediation effect 
of stigma on the relationship between symptoms and poor mental health. Specifically, mood and 
motor symptoms have been linked, such that as motor symptoms decline so do mood symptoms 
(Marsh, 2013). Additionally, relatively little research has examined the roles of social support 
and spirituality as protective factors. Therefore, the purpose of this study was to examine the 
connections among PD symptoms (motor and non-motor), stigma, and mental health problems, 
as well as examine whether social support and spirituality moderated these relationships.  
Hypothesis 1: Research has linked various types of PD symptoms with stigma (Moore & 
Knowles, 2006). Accordingly, it was hypothesized that increased PD symptoms (motor and non-
motor) will be associated with higher levels of stigma. 
Hypothesis 2: Previous research has demonstrated a link between stigma with increased 
apathy, anxiety, and depression (Hatzenbuehler et al., 2013; Meyer, 2003; Oguru et al., 2010). 
Therefore, it was hypothesized that stigma will be associated with higher levels of mental health 
issues (i.e., apathy, anxiety, and depression). 
Hypothesis 3: There is research linking PD symptoms and stigma for individuals with 
PD (Moore & Knowles, 2006). There have also been relationships between stigma and mental 
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health issues (Hatzenbuehler et al., 2013; Meyer, 2003; Oguru et al., 2010). Given these 
previously uncovered relationships, it was hypothesized that stigma will mediate the relationship 
between PD symptoms (motor and non-motor) and mental health (i.e., apathy, anxiety, and 
depression). 
Hypothesis 4: There has been limited research exploring relationships among social 
support, PD symptoms, stigma, and mental health in individuals with PD. However, research has 
demonstrated that social support may protect against a variety of mental health problems (Brod 
et al., 1998; Simpson et al., 2006), stigma (Schrag et al., 2003), and decreased quality of life 
(Takahashi et al., 2016). Based upon the literature review, it was hypothesized that social support 
will moderate relationships among PD symptoms (motor and non-motor), stigma, and mental 
health problems, such that higher levels of social support will weaken these relationships. 
Hypothesis 5: Research with individuals with PD has not explored relationships among 
spirituality, PD symptoms, stigma, and mental health problems. However, research has 
demonstrated that spirituality may protect against a variety of mental health problems, stigma, 
and decreased quality of life (Hermanns, 2013; Reynolds, 2017). It was therefore hypothesized 
that spirituality will moderate the relationships among PD symptoms (motor and non-motor), 
stigma, and mental health, such that higher levels of spirituality will weaken these relationships. 
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Chapter 2 
Methods 
Participants 
 Participants (N = 392) were Parkinson’s disease (PD) patients at a multidisciplinary PD 
clinic in a public, academic medical center in the Mid-Atlantic region of the US. To be eligible 
to participate in the study, PD patients had to: (a) be enrolled in the clinic’s research registry, (b) 
have a physician diagnosis of PD, (c) have baseline (first appointment data), (d) be over the age 
of 18, and (e) be able to read and respond in English. Individuals were ineligible to participate if: 
(a) their primary diagnosis was any non-PD movement disorder diagnosis or unknown clinical 
movement disorder or (b) they had comorbid psychiatric and neurologic diagnoses such as 
bipolar disorder, schizophrenia, epilepsy, or head injury. 
 Demographic information for participants appears in Table 1. The sample was 
predominately White, male, and with at least some college education. While the mean age was 
nearly 70 years old, the youngest participant was 36 and oldest was 88. 
Table 1. Sample Characteristics 
Characteristics (N = 392) 
Age, M (SD) 68.11 (8.78) 
Race/Ethnicity n (%)  
     Caucasian/White 357 (91.1) 
     African American/Black 25 (6.4) 
     Hispanic/Latino 3 (0.8) 
     Asian 3 (0.8) 
     Middle Eastern 1 (0.3) 
     Indian 2 (0.5) 
     Native American 1 (0.3) 
Sex n (%)  
     Female 141 (36.0) 
     Male 251 (64.0) 
Years of Education, M (SD) 15.24 (2.97) 
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A post-hoc power analysis was conducted to determine if the proposed analyses would be 
adequately powered given the sample size. Using G*Power 3.1 (Faul et al., 2007), for a 
moderated mediation (the analysis with the greatest number of parameters with five predictors 
and one criterion variable) a sample size of 392, a .05 alpha level, and power at .80 (1-β), the 
current sample size would be able to identify all large-, medium-, and small-sized effects > f = 
.04. 
Procedure 
 A research registry was queried for all individuals with PD’s first neuropsychological 
evaluation who meet the study inclusion criteria. These individuals had undergone a 
neuropsychological evaluation at the multidisciplinary PD clinic between 2011 and 2019 and 
consented to have their data included into the clinic’s research registry for ongoing and future 
research. As part of the clinical neuropsychological evaluation, individuals with PD completed 
pencil and paper self-report measures examined in the current study in private clinic rooms. The 
neuropsychological evaluation varied by clinician; as such, individuals included in the registry 
may have being assessed using different measures of the same construct. PD symptoms, stigma, 
and social support were assessed through the Parkinson’s Disease Questionnaire-39. PD 
symptoms were also assessed via the Non-Motor Symptoms Questionnaire (PD-NMS). Apathy 
was measured using the Apathy Scale. Anxiety was measured using the Generalized Anxiety 
Disorder-7 or Beck Anxiety Inventory, depression was measured using the Patient Health 
Questionnare-9, Beck Depression Inventory-II, or Geriatric Depression Scale-Short Form, and 
spirituality was assessed using one item of the Linear Analogue Self-Assessment. A variety of 
demographic information was also obtained including age, race/ethnicity, gender, education, 
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marital status, work status and work history. The study was approved by the institution’s ethical 
review board.  
Measures 
 In order to create indices of motor and non-motor symptoms and mental health, measures 
reflecting these constructs were comprised of items from several PD and mental health 
questionnaires. This section will first describe the questionnaires themselves and then describe 
the process for identifying the specific items for inclusion and exclusion, as well as the 
combination process.  
Parkinson’s Disease Questionnaires-39 (PDQ-39). The PDQ-39 was used to assess PD 
symptoms, stigma, and social support (Peto et al., 1998). The stigma and social support subscales 
were used. The remaining items were evaluated and sorted into motor and non-motor symptom 
categories as described below. Subscale scores (included motor and non-motor symptoms) were 
obtained by totaling the raw score, dividing by the total number of items in the subscale, and 
multiplying by 100. Scores range from 0 (no problem at all) to 100 (maximum possible score) 
for each subscale, with higher scores representing greater symptoms, higher stigma, or lower 
social support. In a validation study of the PDQ-39, internal validity was acceptable or better for 
all subscales (expect social support at time one; α = .76), and the internal reliability for the total 
score was good (α = .84, .89) across two clinical samples (Peto et al., 1998). In the current study, 
the internal reliability of the total scale was excellent (α = .96); by subscales the internal 
reliability of mobility (α = .94), cognitions (α = .73), bodily discomfort (α = .73), activities of 
daily living (α = .89), emotional well-being (α = .90), stigma (α = .87), and social support (α = 
.74) were acceptable to excellent. 
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 Non-Motor Symptoms Questionnaire (NMS). Symptoms of PD were also assessed 
using the 30-item NMS (Martinez-Martin et al., 2007). Individuals are presented a range of 
possible problems they may have experienced in the previous month and asked to respond “yes” 
or “no” as to whether they have experienced the symptom. Each “yes” response is given a value 
of one and a total score is calculated, with higher scores representing more severe symptoms. 
Items were evaluated and sorted into motor and non-motor symptom categories as described 
below. Internal reliability averaged across nine domains was questionable (α = .61) in a pilot 
study (Chaudhuri et al., 2007). In the current study, the internal reliability of the scale was good 
(α = .81). 
Apathy Scale (AS). Apathy was assessed using the 14-item AS (Starkstein et al., 1992). 
Items use a four-point Likert-type scale, with total scores ranging from 0 to 42. Higher scores 
represent higher apathy. A score of 14 or higher indicates clinically significant levels of apathy 
in PD. This scale had acceptable internal reliability (α = .76) in validation studies with PD 
patients (Starkstein et al., 1992). In the current study, the internal reliability of the full scale was 
good (α = .80), and with two excluded items was acceptable (α = .77). 
Generalized Anxiety Disorder-7 (GAD-7). Anxiety was assessed using the GAD-7 
(Spitzer et al., 2006). Individuals use a Likert-type scale ranging from 0 (“not at all”) to 3 
(“nearly every day”) to respond to seven items. Total scores are summed with possible scores 
ranging from 0 to 21. Scores of 0 to 4 indicate minimal severity, 5 to 9 mild severity, 10 to 14 
moderate severity, and 15 to 21 severe anxiety. This scale had excellent internal reliability (α = 
.92) in a validation study of primary care clinic patients (Spitzer et al., 2006). In the current 
study, the internal reliability of the full scale was excellent (α = .91). 
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Beck Anxiety Inventory (BAI). Anxiety was also be assessed using the BAI (Beck, 
Epstein, Brown, & Steer, 1988). The 21-item scale response options range from 0 (“not at all) to 
3 (“severely – it bothered me a lot”). Scores of 0-7 reflect minimal anxiety, 8-15 mild anxiety 
16-25 moderate anxiety, and 26-63 severe anxiety. This scale has excellent internal reliability (α 
= .92) in a validation study of psychiatric outpatients (Beck, Epstein, Brown, & Steer, 1988). In 
the current study, the internal reliability of the full scale was good (α = .88), and with nine 
excluded items was good (α = .83). 
Beck Depression Inventory-II (BDI-II). Depression was assessed using the BDI (Beck, 
Steer, & Brown, 1996; Dozois, Dobson, & Ahnberg, 1998). This 21-item self-report measure has 
response items on a four-point scale. Scores of 0-13 indicate minimal depression, 14-19 mild, 
20-28 moderate, and 29-63 severe. This scale has excellent internal consistency among college 
students (α = .93) and clinical outpatients (α = .92) (Beck et al., 1996; Dozois et al., 1998). In the 
current study, the internal reliability of the full scale was excellent (α = .90), and with three 
excluded items was excellent (α = .90). 
Patient Health Questionnare-9 (PHQ-9). Depression was measured using the PHQ-9 
(Kroenke et al., 2001). Responses to this nine-item measure are on a Likert-type scale ranging 
from 0 (“not at all”) to 3 (“nearly every day”). Total scores are summed, with 5 to 9 indicating 
mild, 10 to 14 moderate, 15 to 19 moderately severe, and 20 to 27 severe depressive 
symptomatology. This scale had good internal reliability (α = .89) in a validation study of 
primary care clinic patients (Kroenke et al., 2001). In the current study, the internal reliability of 
the full scale was good (α = .86), and with two excluded items was good (α = .84). 
Geriatric Depression Scale Short Form (GDS-SF). The GDS-SF was also be used to 
assess depression (Sheikh & Yesavage, 1986). This scale is a 15-item self-report measure with 
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“yes/no” response options. Scores of 0-4 are normal, 5-8 mild, 8-11 moderate, and 12-15 severe 
depression. This scale had excellent internal reliability (α = .92) in a study of Parkinson’s 
patients (Ertan et al., 2005). In the current study, the internal reliability of the full scale was good 
(α = .85), and with one excluded item was good (α = .84). 
Linear Analogue Self-Assessment (LASA). Spirituality was assessed using the LASA 
(Locke et al., 2007). The LASA comprises of five quality of life items—including spirituality—
with functioning of each rated on zero to ten scale (zero being the worst, ten being the best). 
Only the single spirituality item will be used for this study.  
Measure Screening 
 The motor and non-motor symptom measures were composed of items from both the 
PDQ-39 and NMS. Duplicate items were screened for across the PDQ-39 and NMS. Using 
current PD criteria of motor and non-motor symptoms and clinician review, items were coded as 
either motor or non-motor. Four duplicate items were found, and the NMS items were retained, 
as the PDQ-39 are often considered quality of life measures. Six items from the PDQ-39 were 
eliminated as they overlapped with mental health constructs. This left 21 items other than the 
stigma and social support items. One item was rejected because it did not fit clear symptom 
categories and appeared to more closely approximate the stigma items. This left 16 items that 
were coded as motor and four non-motor from the PDQ-39. From the NMS, three items were 
coded as motor based on clinician review, and 22 were coded as non-motor. Three items were 
excluded for duplicating mental health constructs, and two were excluded for not clearly fitting 
into motor or non-motor categories. Overall, 19 items were coded as motor and 26 non-motor. 
For scoring purposes, items were converted into z-scores and summed. 
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 The mental health composite variable was the average of completed mental health scores 
including the apathy z-score, anxiety z-score (averaged if both measures completed), and 
depression z-score (averaged across completed measures). To be included, participants had to 
have completed at least two of three mental health domains (i.e., apathy, anxiety, and 
depression). The mental health measures all had the physical health and PD symptoms removed, 
which resulted in nine items being excluded from the BAI, three from the BDI-II, two from the 
PHQ-9, and one from the GDS-SF. The mental health scales were also examined for overlapping 
constructs, which resulted in two items being excluded from apathy. 
Data Analysis Plan 
In addition the eligibility criteria, data was further screened whereby individuals must 
have completed (a) at least 50% of items by subscale for the PDQ-39, (b) at least two out of three 
indices of mental health with at least 50% of items completed, (c) at least 50% of items 
completed on the NMS. A Little’s missing completely at random (MCAR) test was run to 
examine if data is missing at random. Following the MCAR test, missing data was imputed using 
expectation maximization. 
Preliminary Analyses. Prior to conducting the primary statistical analyses to investigate 
the study’s hypotheses, normality tests (i.e., skewness and kurtosis) were performed to establish 
if the study scales and subscales are distributed normally. Skewness and kurtosis were identified 
using a critical value of 2.0. If abnormal distributions are detected, data transformation were 
employed where appropriate for corrections. Multicollinearity was assessed via correlation 
coefficients among all independent variables (with a goal of r < .70 among all predictors). 
Primary Analyses. Two base mediations and four moderated mediation models were developed 
using the PROCESS macro (Hayes, 2017). In the mediation models (Model 4), motor or non-
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motor PD symptoms were specified to lead to stigma, which was then specified to lead to a 
composite (average z-score) mental health variable comprised of apathy, anxiety, and/or 
depression; see Figure 1). The mediations were examined differentially as a function of 
participants’ social support and spirituality (Model 59; Figure 2). To address H1 and H2, the 
direct effects of PD symptoms to stigma and stigma to mental health problems were examined 
(see Figure 1).  
Figure 1  
Conceptual Model of Proposed mediation of PD Symptoms, Stigma, and Mental Health 
Problems 
 
To address H3, the indirect effects of PD symptoms to mental health problems through stigma 
was examined (see Figure 1). The interactions of the moderated mediations (social support and 
spirituality; see Figure 2) were examined to address H4 and H5.  
Figure 2 
Conceptual Model of Proposed moderated mediation of PD Symptoms, Stigma, and Mental 
Health Problems by Social Support or Spirituality 
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To identify unique contributions among patterns of connections among PD symptoms, 
stigma, and mental health problems in individuals with PD, a series of simultaneous multiple 
regressions were performed. The first regression included the motor and non-motor PD 
symptoms as the predictors and stigma as the criterion variable. The second through fourth 
regressions included motor and non-motor PD symptoms as the predictors and mental health 
problems (i.e., one each for apathy, anxiety, and depression) as the criterion variable. For any 
demographic variable shown in a correlation matrix to be associated with an outcome, that 
demographic variable was controlled for in the regression models. 
Results 
Preliminary Analyses  
Data cleaning. In addition the eligibility criteria, data was further screened whereby 
participants must have completed (a) at least 50% of items by subscale for the PDQ-39, (b) at 
least two out of three indices of mental health with at least 50% of items completed, (c) at least 
50% of items completed on the NMS. To determine whether data were missing at random, a 
Little’s missing completely at random (MCAR) test was conducted. Data were determined to be 
missing at random for apathy (three missing; p = .925), BAI (five missing; p = .519), and GAD-7 
(one missing; p = .288); however, not for the PHQ-9 (p =.001), from which only two responses 
were missing. There were no missing data in the PDQ-39, NMS, BDI-II, and GDS-SF. 
Following the MCAR test, missing item-level data were imputed using expectation maximization 
within the same scale.  
Normality and multicollinearity assumptions. Normality tests (i.e., skewness and 
kurtosis) were performed to establish if the study scales and subscales were distributed normally. 
Skewed or kurtotic variables were identified using a critical value of +/- 2.0 (see Table 2).  
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Table 2. Skewness and Kurtosis Statistics for Study Variables 
Variable  Skewness Kurtosis 
Motor Symptoms 1.12 0.63 
Non-motor Symptoms 0.82 0.76 
Stigma 1.77 3.05 
Mental Health Problems 1.03 1.37 
Social Support -2.25 5.62 
Spirituality -1.06 1.02 
   
Most variables were generally within the cutoff or slightly above for both skewness and kurtosis, 
social support was very kurtotic. Data transformations were attempted; however, the original 
variable was retained as attempts at transformations only increased how kurtotic the variable 
was. Next a correlation matrix was created with all variables (see Table 3). 
Table 3. Correlations of Primary Study Variables 
  1 2 3 4 5 
1. Motor Symptoms 
     
2. Non-motor Symptoms .610** 
    
3. Stigma .478** .402** 
   
4. Social Support -.426** -.522** -.445** 
  
5. Spirituality -.287** -.363** -.273** .383** 
 
6. Mental Health Problems .475** .592** .439** -.450** -.528** 
Note. ** p < .01 
  
Additionally, a correlation matrix was created to examine bivariate relationships among 
demographic variables (age, sex, and years of education) and study variables (see Table 4). 
Table 4. Correlation Matrix with Demographic Variables  
Variable Age 
Sex (0 = female, 
1 = male) 
Education 
Motor Symptoms .110* -.078 -.186** 
Non-motor Symptoms -.079 -.151** -.144** 
Stigma -.277** -.050 -.108* 
Social Support .111* .099* .023 
Spirituality .048 .061 -.008 
Mental Health Problems -.100* -.068 -.219** 
Note. *p < .05, **p < .01 
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No data exceeded the threshold (r < .70 among all predictors) for multicollinearity via 
correlation coefficients among all independent variables. 
 Motor symptoms were positively correlated with non-motor symptoms. Both symptoms 
types were positively correlated with stigma and mental health problems, and negatively 
correlated with social support and spirituality. Stigma was negatively correlated with social 
support and spirituality, and positively correlated with mental health problems. Social support 
and spirituality were positively correlated with each other, and both negatively correlated with 
mental health problems. Age was positively associated with motor symptoms and social support, 
and negatively associated with stigma and mental health problems. Sex was negatively 
associated with non-motor symptoms such that females reported more non-motor symptoms, and 
positively associated with social support such that males reported higher levels of social support. 
Education was negatively correlated with motor symptoms, non-motor symptoms, stigma, and 
mental health problems. 
 Outliers. The database was checked for univariate and multivariate outliers. To assess for 
univariate outliers, the motor symptoms, non-motor symptoms, stigma, mental health composite, 
spirituality, and social support variables were all converted into z-scores. A cutoff of =/- 3.0 was 
used to identify univariate outliers. Only stigma (2.6%) and social support (2.8%) exceeded the 
1% recommendation for retention by Cohen et al. (2003). As the outliers were not extreme, had 
reasonable values, and still a small proportion of the sample, all the data were retained. 
 To identify multivariate outliers, Mahalanobis distance (D2) was computed. With five 
degrees of freedom and at α = .001, the critical value for detecting multivariate outliers was +/- 
20.515. Three multivariate outliers were identified, with the following critical values: 31.587, 
29.243, and 27.796. These participants responses were reviewed again, and although extreme, 
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they were generally consistent with expected patterns. For example, the person with the highest 
Mahalanobis distance had high symptoms, high stigma, high mental health problems, and low 
social support. As the three multivariate outliers generally fell within expected patterns without 
appearing otherwise random or problematic, their scores were retained. 
Descriptive statistics. The descriptive statistics (i.e., means, standard deviations) of 
participants’ symptoms, stigma, mental health (apathy, anxiety, and depression), social support, 
and religious well-being appear in Table 5. 
Table 5. Means and Standard Deviations for Study Variables.  
Variable N Mean (SD) Range 
Motor symptoms 392 9 (5.4) 0-19 
Non-motor symptoms 392 9 (4.4) 0-23 
Stigma 392 16.20 (21.20) 0-100 
Social Support 392 90.10 (17.03) 8.33-100 
Spirituality 349 7.77 (2.02) 0-10 
Apathy 390 11.60 (5.92) 0-34 
Anxiety    
BAI 274 9.68 (7.67) 0-40 
GAD-7 158 4.28 (4.92) 0-21 
Depression    
BDI 287 9.69 (7.61) 0-45 
PHQ-9 155 6.26 (5.52) 0-25 
GDS-SF 70 4.19 (3.58) 0-14 
Note. The means and ranges reflect all items in the original measure. 
 
Based on the clinical cutoff of 14 for apathy, 30.5% of individuals had significant levels of 
apathy. Of those who completed the BAI, 43.8% had minimal anxiety, 37.2% had mild anxiety, 
14.2% had moderate anxiety, and 4.7% severe anxiety. Of those who completed the GAD-7, 
65.2% had minimal, 20.9% had mild, 8.2% had moderate, and 5.7% had severe anxiety. Of those 
who completed the BDI-II, 76.0% had minimal, 13.9% had mild, 7.3% had moderate, and 2.8% 
had severe depression. Of those who completed the PHQ-9, 28.4% had mild, 12.3% had 
moderate, 5.8% had moderately severe, and 4.5% had severe depression. Of those who 
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completed the GDS-SF, 61.4% were in the normal range, 27.1% mild and 11.5% moderate, and 
nobody scored in the severe depression range. 
Primary Analyses 
 Two base mediation models expanded into four moderated mediation models were 
developed using the PROCESS macro (Hayes, 2017). In these models, motor or non-motor PD 
symptoms were specified to lead to stigma, which was then specified to lead to a composite (z-
score average) mental health variable comprised of apathy, anxiety, and depression. The 
mediations were examined differentially as a function of participants’ social support and 
spirituality (Figure 2). 
Mediations: The Hayes PROCESS macro was used to conduct two meditational models 
(Model 4) to examine patterns of relationships that emerged among the primary study variables. 
In the first mediation, motor PD symptoms was specified to have a direct effect on mental health 
problems, as well as an indirect effect through stigma, using 5,000 bootstrap samples. The direct 
paths from motor PD symptoms to stigma (b = .037, p < .001) and from stigma to mental health 
problems (b = .204, p < .001) were both statistically significant. Further, the indirect effect of 
motor PD symptoms on mental health problems through stigma was statistically significant (b = 
.008, 95% CI [.004, .012]), indicating a partial mediation because the direct path from motor PD 
symptoms to mental health problems was still statistically significant in the model (b = .020, p < 
.001). 
For the second mediation, non-motor PD symptoms was specified to have a direct effect 
on mental health problems, as well as an indirect effect through stigma, using 5,000 bootstrap 
samples. The direct paths from non-motor PD symptoms to stigma (b = .038, p < .001) and from 
stigma to mental health problems (b = .178, p < .001) were both statistically significant. Further, 
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the indirect effect of non-motor PD symptoms on mental health problems through stigma was 
statistically significant (b = .007, 95% CI [.003, .011]), indicating a partial mediation because the 
direct path from non-motor PD symptoms to mental health problems was still statistically 
significant in the model (b = .035, p < .001). 
Moderated mediation: Motor PD symptoms as predictor and social support as 
moderator. In the first moderated mediation (Model 59), motor PD symptoms was specified to 
have a direct effect on mental health problems, as well as an indirect effect through stigma, using 
5,000 bootstrap samples. The direct paths from motor PD symptoms to stigma (b = .352, p < 
.001) and from stigma to mental health problems (b = .106, p = .006) were both statistically 
significant. Further, the direct path from motor PD symptoms to mental health problems was 
statistically significant in the model (b = .232, p < .001). 
Next it was examined whether the mediational effect from motor PD symptoms through 
stigma to mental health problems differed as a function of participants’ level of social support. 
The overall model predicting mental health problems was significant, F(5, 386) = 41.276, p < 
.001, R2 = .348. Table 6 presents the b-weights, standard errors, p-values, and 95% bias-correct 
bootstrap confidence intervals for each of the paths included in the moderated-mediation model. 
The motor PD symptoms x social support interaction with stigma as the criterion variable was 
not significant (b = -.001, p = .978). When mental health problems were the criterion, the 
interactions between motor PD symptoms x social support (b = .088, p = .003; Figure 3) and 
stigma x social support (b = -.081, p = .002; Figure 4) were significant. A regression was run to 
examine a potential effect of multicollinearity (due to two interaction terms being used in the 
same PROCESS model) on the direction of the motor PD symptoms x social support moderation, 
as the effect of high social support is not in the expected direction. While the overall model was 
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significant F(3, 388) = 56.511, p < .001, R2 = .304, the interaction was not (β =.073, p = .161). 
This suggests that the direction may be an artifact of multicollinearity in the model. 
Table 6. Model Summary for the Association between Motor PD Symptoms and Mental Health 
Problems through Stigma by Social Support (N = 392).  
Social Support Estimate (SE) 
95% Bias-corrected bootstrap 
confidence interval 
Model 1: DV = Stigma 
    Motor Symptoms .35(.05)*** .26 to .44 
    Social Support -.29(.05)*** -.40 to -.19 
    Motor Symptoms × Social Support -.001(.03) -.07 to .07 
    R2 .30***  
Model 2: DV = Mental Health 
    Motor Symptoms .23 (.04)*** .16 to .30 
    Stigma .11(.04)** .03 to .18 
    Social Support -.18(.04)*** -.26 to -.10 
    Motor Symptoms × Social Support .09(.03)** .03 to .15 
    Stigma × Social Support -.08(.03)** -.13 to -.03 
    R2 .35***  
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001. 
 
Figure 3  
 
Moderation of motor PD symptoms to mental health by levels of social support found to be an 
artifact of multicollinearity 
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Figure 4  
Moderation of stigma to mental health by levels of social support 
 
Follow-up analyses examined the conditional effects at different levels of the moderator 
(social support). There were conditional direct and indirect effects of motor PD symptoms on 
mental health problems by social support. Specifically, motor PD symptoms had a larger direct 
effect on mental health problems for participants with high social support relative to those with 
low social support, suggesting an accelerating effect of social support on this direct effect 
inconsistent with H4 but reflective of error and an artifact of multicollinearity devoid of meaning 
(Table 7). Conversely, the indirect effect of motor PD symptoms on mental health problems 
through stigma was stronger at lower levels of social support than at high levels, suggesting that 
this mediational model held only for those with low social support and therefore a buffering 
effect consistent with H4 and supporting a moderated mediation (Table 8). 
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Table 7. Conditional Direct Effects of Motor PD Symptoms on Mental Health Problems at 
Levels of Social Support (N = 392) 
Social 
Support 
Effect Estimate (SE) 
95% Bias-corrected bootstrap confidence 
interval 
Low .15* .04 .07 to .24 
High .28* .04 .20 to .37 
Note. *Effects are considered statistically significant if the p value is < .05 and the 95% bias-
corrected bootstrap confidence interval does not encapsulate zero.  
  
Table 8. Conditional Indirect Effects of Motor PD Symptoms on Mental Health Problems at 
Levels of Social Support (N = 392) 
Social 
Support  
Effect Estimate (SE) 
95% Bias-corrected bootstrap confidence 
interval 
Low .06* .02 .02 to .11 
High .02 .02 -.02 to .06 
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap 
confidence interval does not encapsulate zero. 
  
Moderated mediation: Non-motor symptoms as predictor and social support as 
moderator. In the second moderated mediation (Model 59), non-motor PD symptoms was 
specified to have a direct effect on mental health problems, as well as an indirect effect through 
stigma, using 5,000 bootstrap samples. The direct paths from non-motor PD symptoms to stigma 
(b = .229, p < .001) and from stigma to mental health problems (b = .130, p < .001) were both 
statistically significant. Further, the direct path from non-motor PD symptoms to mental health 
problems was statistically significant in the model (b = .341, p < .001). 
Next, it was examined whether the mediational effect from non-motor PD symptoms 
through stigma to mental health differed as a function of participants’ level of social support. The 
overall model predicting mental health was significant, F(5, 386) = 55.182, p < .001, R2 = .417. 
Table 9 presents the b-weights, standard errors, p-values, and 95% bias-correct bootstrap 
confidence intervals for each of the paths included in the moderated-mediation model. The non-
motor PD symptoms x social support interaction with stigma as the criterion variable was not 
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significant (b = -.023, p = .501). When mental health was the criterion, the interaction between 
non-motor PD symptoms x social support was not significant (b = .037, p = .146), while stigma x 
social support was significant (b = -.050, p = .031; Figure 5).  
Table 9. Model Summary for the Association between Non-Motor Symptoms and Mental Health 
through Stigma by Social Support (N = 392).  
Social Support Estimate (SE) 
95% Bias-corrected bootstrap 
confidence interval 
Model 1: DV = Stigma 
    Non-Motor Symptoms .23(.05)*** .13 to .33 
    Social Support -.30(.06)*** -.42 to -.18 
    Non-Motor Symptoms × Social Support -.02(.03) -.09 to .04 
    R2 .24***  
Model 2: DV = Mental Health 
    Non-Motor Symptoms .34(.04)*** .27 to .41 
    Stigma .13(.03)*** .06 to .20 
    Social Support -.09(.04)* -.17 to -.004 
    Non-Motor Symptoms × Social Support .04(.03) -.01 to .09 
    Stigma × Social Support -.05(.02)* -.10 to -.005 
    R2 .42***  
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001. 
  
Figure 5  
Moderation of stigma to mental health by levels of social support 
 
Follow-up analyses examined the indirect effect at different levels of the moderator 
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statistical significance and non-significance, the size of the indirect effect did decrease in the 
hypothesized direction (H4).  
Table 10. Conditional Indirect Effects of Non-Motor PD Symptoms on Mental Health at Levels 
of Social Support (N = 392) 
Social Support  Effect Estimate (SE) 
95% Bias-corrected 
bootstrap confidence 
interval 
Low .04* .02 .01 to .09 
High .02* .01 .001 to .05 
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap 
confidence interval does not encapsulate zero. 
  
Moderated mediation: Motor symptoms as predictor and spirituality as moderator. 
In the third moderated mediation model, motor PD symptoms was specified to have a direct 
effect on mental health, as well as an indirect effect through stigma, using 5,000 bootstrap 
samples. The direct paths from motor PD symptoms to stigma (b = .427, p < .001) and from 
stigma to mental health (b = .161, p < .001) were both statistically significant. Further, the direct 
path from motor PD symptoms to mental health was statistically significant in the model (b = 
.187, p < .001). 
Next, it was examined whether the mediational effect from motor PD symptoms through 
stigma to mental health problems differed as a function of participants’ level of spirituality. The 
overall model predicting mental health was significant, F(5, 343) = 55.367, p < .001, R2 = .447. 
Table 11 presents the b-weights, standard errors, p-values, and 95% bias-correct bootstrap 
confidence intervals for each of the paths included in the moderated-mediation model. The motor 
PD symptoms x spirituality interaction with stigma as the criterion variable was not significant (b 
= -.08, p = .053). When mental health was the criterion, both the interactions between motor PD 
symptoms x spirituality (b = .08, p = .019; Figure 6) and stigma x spirituality were significant (b 
= -.07, p = .017; Figure 7). A regression was run to examine a potential effect of 
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multicollinearity on the direction of the motor PD symptoms x spirituality moderation, as the 
effect of high spirituality was not in the expected direction. While the overall model was 
significant F(3, 345) = 75.290, p < .001, R2 = .396, the interaction was not (β =.037, p = .402). 
This suggests again that the direction of the interaction is an artifact of multicollinearity in the 
model devoid of meaning. 
Table 11. Model Summary for the Association between Motor Symptoms and Mental Health through 
Stigma by Spirituality (N = 349).  
Spirituality 
Estimate 
(SE) 
95% Bias-corrected bootstrap 
confidence interval 
Model 1: DV = Stigma 
    Motor Symptoms .43(.05)*** .34 to .52 
    Spirituality -.12(.05)** -.21 to -.02 
    Motor Symptoms × Spirituality -.08(.04) -.17 to .001 
    R2 .27***  
Model 2: DV = Mental Health 
    Motor Symptoms .19(.03)*** .12 to .04 
    Stigma .16(.04)*** .09 to .23 
    Spirituality -.29(.03)*** -.36 to -.23 
    Motor Symptoms × Spirituality .08(.03)** .01 to .14 
    Stigma × Spirituality -.07(.03)** -.12 to -.01 
    R2 .45***  
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001. 
  
Figure 6  
 
Moderation of motor PD symptoms to mental health by levels of spirituality found to be an 
artifact of multicollinearity 
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Figure 7  
Moderation of stigma to mental health by levels of spirituality 
 
Follow-up analyses examined the conditional effects at different levels of the moderator 
(spirituality). There were conditional direct and indirect effects of motor PD symptoms on 
mental health by spirituality. Specifically, motor PD symptoms had a larger direct effect on 
mental health problems for participants with high spirituality relative to those with low or mid 
spirituality, suggesting an intensifying effect of spirituality on this direct effect inconsistent with 
H5 but reflective of error and an artifact of multicollinearity devoid of meaning (Table 12). 
Conversely, the indirect effect of motor PD symptoms on mental health problems through stigma 
was stronger at lower levels of spirituality than at high levels, suggesting that this mediational 
model only held for those with low and mid spirituality and therefore a buffering effect 
consistent with H5 and supporting a moderated mediation (Table 13). 
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Table 12. Conditional Direct Effects of Motor PD Symptoms on Mental Health at Levels of 
Spirituality (N = 349) 
Spirituality Effect Estimate (SE) 
95% Bias-corrected 
bootstrap confidence 
interval 
Low .12* .04 .04 to .20 
Mid .20* .03 .13 to .26 
High .27* .05 .17 to .37 
Note. *Effects are considered statistically significant if the p value is < .05 and the 95% bias-
corrected bootstrap confidence interval does not encapsulate zero.  
 
Table 13. Conditional Indirect Effects of Motor PD Symptoms on Mental Health at Levels of 
Spirituality (N = 349) 
Spirituality Effect Estimate (SE) 
95% Bias-corrected 
bootstrap confidence 
interval 
Low .11* .03 .04 to .18 
Mid .06* .03 .02 to .12 
High .03 .03 -.02 to .10 
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap 
confidence interval does not encapsulate zero. 
  
Moderated mediation: Non-motor symptoms as predictor and spirituality as 
moderator. In the fourth moderated mediation model, non-motor PD symptoms was specified to 
have a direct effect on mental health, as well as an indirect effect through stigma, using 5,000 
bootstrap samples. The direct paths from non-motor PD symptoms to stigma (b = .343, p < .001) 
and from stigma to mental health (b = .151, p < .001) were both statistically significant. Further, 
the direct path from non-motor PD symptoms to mental health was statistically significant in the 
model (b = .281, p < .001). 
Next, it was examined whether the mediational effect from non-motor PD symptoms 
through stigma to mental health differed as a function of participants’ level of spirituality. The 
overall model predicting mental health was significant, F(5, 343) = 70.002, p < .001, R2 = .505. 
Table 14 presents the b-weights, standard errors, p-values, and 95% bias-correct bootstrap 
confidence intervals for each of the paths included in the moderated-mediation model. The non-
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motor PD symptoms x spirituality interaction with stigma as the criterion variable was not 
significant (b = -.052, p = .174). When mental health was the criterion, the interaction between 
non-motor PD symptoms x spirituality (b = -.002, p = .940) and stigma x spirituality were also 
not significant (b = -.025, p = .346). These results indicate no pattern of interactions with 
spirituality. Two regressions were run to examine a potential effect of multicollinearity (due to 
two interaction terms being used in the same PROCESS model) on the interaction of nonmotor 
PD symptoms x spirituality and stigma x spirituality. For nonmotor PD symptoms x spirituality, 
the overall model was significant F(3, 345) = 30.098, p < .001, R2 = .464; however, the 
interaction was not (β = -.039, p = .355). The same was true for stigma x spirituality, with the 
overall model being significant F(3, 345) = 25.168, p < .001, R2 = .392, while the interaction was 
not (β = -.055, p = .225). This supports the findings of the PROCESS model and suggests this 
was not a result of multicollinearity in the model. 
Table 14. Model Summary for the Association between Non-Motor Symptoms and Mental Health 
through Stigma by Spirituality (N = 349).  
Spirituality Estimate (SE) 
95% Bias-corrected bootstrap confidence 
interval 
Model 1: DV = Stigma 
Non-Motor Symptoms .34(.05)*** .24 to .44 
Spirituality -.12(.05)** -.23 to -.02 
Non-Motor Symptoms × Spirituality -.05(.04) -.13 to .02 
R2 .44***  
Model 2: DV = Mental Health 
Non-Motor Symptoms .28(.03)*** .22 to .34 
Stigma .15(.03)*** .09 to .21 
Spirituality -.24(.03)*** -.30 to -.18 
Non-Motor Symptoms × Spirituality -.002(.03) -.05 to .05 
Stigma × Spirituality -.03(.03) -.08 to .03 
R2 .51***  
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001. 
  
Follow-up analyses examined the indirect effect at different levels of the moderator 
(spirituality; Table 15). The indirect effect of non-motor PD symptoms on mental health 
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problems through stigma was stronger at low and mid-levels of spiritualty than at high levels, 
suggesting that this mediational model held only for those with low and mid-spirituality and 
therefore a buffering effect consistent with H5. 
Table 15. Conditional Indirect Effects of Non-Motor PD Symptoms on Mental Health at Levels 
of Spirituality (N = 349) 
Spirituality Effect Estimate (SE) 
95% Bias-corrected 
bootstrap confidence 
interval 
Low .07* .03 .02 to .12 
Mid .05* .02 .01 to .10 
High .04 .03 -.003 to .10 
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap 
confidence interval does not encapsulate zero. 
  
Regressions. In order to identify the patterns of connections among PD symptoms, 
stigma, and mental health, a series of hierarchical multiple regressions were performed using 
SPSS Software Package, Version 26. In the first hierarchical multiple regression, age was 
entered in the first step, motor and non-motor symptoms in the second, and stigma as the 
outcome. The overall model was significant and explained 34.4% of variance in stigma [F(3, 
388) = 67.77, p < .001, R2 = .344]. When considering each symptom type separately, only the 
motor symptoms uniquely predicted stigma (β =.450, p < .001), while non-motor (β =.102, p = 
.055) did not. Age was also a unique predictor (β = -.318, p < .001) of stigma. 
 In the second hierarchical multiple regression, age and education were entered in the first 
step, motor and non-motor symptoms in the second, with apathy as the outcome. The overall 
model was significant and explained 11.1% of variance in apathy [F(4, 386) = 12.01, p < .001, 
R2 = .111]. When considering each symptom type separately, both the motor symptoms (β 
=.176, p = .005) and non-motor (β =.153, p = .014) uniquely predicted apathy. Age (β = .063, p = 
.201) and years of education (β = -.093, p = .059) were not unique predicators of apathy. 
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 In the third hierarchical multiple regression, age and education were entered in the first 
step, motor and non-motor symptoms in the second, with stigma as the outcome. The overall 
model was significant and explained 33.2% of variance in stigma [F(4, 386) = 47.92, p < .001, 
R2 = .332]. When considering each symptom type separately, only the non-motor symptoms 
uniquely predicted anxiety (β =.477, p < .001), while motor (β =.095, p = .082) did not. Age was 
also a unique predictor (β = -.123, p = .004) of anxiety, while years of education (β = -.070, p = 
.102) was not. 
 In the fourth hierarchical multiple regression, age and education were entered in the first 
step, motor and non-motor symptoms in the second, with depression as the outcome. The overall 
model was significant and explained 38.3% of variance in stigma [F(4, 386) = 59.96, p < .001, 
R2 = .383]. When considering each symptom type separately, both the motor symptoms (β 
=.152, p = .004) and non-motor (β =.465, p < .001) uniquely predicted depression. Age (β = -
.134, p = .001) and years of education (β = -.108, p = .008) were also was also unique predictors 
of depression. 
Discussion 
 As incidence of PD rises, so too does the need to examine the social consequences of PD. 
Such consequences include increased experiences of stigma as a results of symptoms of PD 
(Moore & Knowles, 2006). Individuals with PD who experience higher rates of stigma may 
isolate and withdraw themselves as a result of negative and stigmatizing experiences (Burgener 
& Berger, 2008), which may ultimately lead to poorer mental health outcomes (Hatzenbuehler et 
al., 2013; Mak et al., 2007; Meyer, 2003; Pascoe & Smart Richman, 2009). Relatively little 
research exists examining the potential mediation effect of stigma on the relationship between 
symptoms and poor mental health or on the role of social support and spirituality as potential 
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protective factors. This study sought to examine the connections among PD symptoms (motor 
and non-motor), stigma, and mental health problems, as well as examine whether social support 
and spirituality moderated these relationships.  
Descriptives 
 Symptoms. In the current study, participants reported an average of nine motor 
symptoms and nine non-motor symptoms. These motor and non-motor symptom averages were 
composed of items from both the PDQ-39 and NMS, and therefore the rates cannot be compared 
directly to other studies. However, the rate of non-motor symptoms was very similar to the 
overall average reported by Martinez-Martin and colleagues (2007) of 10.25 non-motor 
symptoms (SD = 5.3; range 0-28), with a range by country from a low of 9.28 (SD = 4.3) in Italy 
and high of 12.71 (SD = 5.7) in Israel (Martinez‐Martin et al., 2007) of the six countries included 
in the study. To the author’s knowledge, no similar assessment exists for motor symptoms. 
Apathy. In the current study, 37.2% of the sample reported significant levels of apathy. 
This rate is comparable with previous research which suggests apathy occurs for approximately 
40% of individuals with PD (Brok et al., 2015) as well as in 20-36% of newly diagnosed 
individuals (Pagonabarraga et al., 2015). As data were collected during participants’ first 
neuropsychological evaluation, this comparison makes sense. It is, however, unknown whether 
this first assessment was a patient’s first time being seen at the clinic having had a previous 
diagnosis or if they were newly diagnosed patients. This distinction may be important as levels 
of apathy vary across the disease course (Dujardin et al., 2007; Pluck & Brown, 2002; Wee et al., 
2016). 
 Anxiety. In the current study, of those who completed the BAI, 56.1% had at least mild 
anxiety. Of those who completed the GAD-7, 34.8% had at least mild anxiety. While the GAD-7 
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rates are in line with previous research, the BAI figures greatly exceeded the estimated rates of 
25% to 40% of individuals with PD who will experience clinically significant anxiety (Kano et 
al., 2011; Pontone et al., 2009; Quelhas & Costa, 2009; Starkstein, Robinson, Leiguarda, & 
Preziosi, 1993; Walsh & Bennett, 2001). There are several possible reasons for the differences in 
the performance of the BAI and GAD-7. These include the number of individuals administered 
each measure (BAI N = 274; GAD-7 N = 158). Other reasons why the BAI may indicate higher 
levels of anxiety include that anxiety is part of prodromal syndrome of PD (Chen et al., 2015; 
Jacob et al., 2010) and many individuals may experience anxiety related to specific PD 
symptoms (Coakeley et al., 2014; Dissanayaka et al., 2016; Martens et al., 2016). These may be 
better captured by the items of the BAI than the GAD-7. 
 Depression. In the current study, of those who completed the BDI-II, 24% of individuals 
had at least mild depression. Of those who completed the PHQ-9, 51% had at least mild 
depression. Of those who completed the GDS-SF, 38.5% had at least mild depression, with no 
participants scoring in the severe depression range. It is noteworthy that the GDS-SF did not 
record severe depression compared to the BDI-II or the PHQ-9. There are several possible 
explanations for this. The first is that the constructs being measured by the GDS-SF, BDI-II and 
PHQ-9 may be slightly different. However, in a study comparing nine different depression scales 
in PD patients, it was suggested that all nine performed equally well with the exception of the 
Unified Parkinson's Disease Rating Scale for Depression (Williams et al., 2012). Furthermore, 
the GDS-SF was only administered to those age 65 and above, so it may be that there may be 
something significant about older PD patients or unique about this group of older PD patients. 
Overall, those administered the PHQ-9 reported the highest levels of depression, followed by the 
BDI-II, and the GDS-SF. The rates of depression indicated by the BDI-II were only slightly 
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higher than other studies, while the PHQ-9 was significantly higher (Quelhas & Costa, 2009). 
This again may be a result of differences in the measures or in the patients who were 
administered the measures. There is also significantly more data from the BDI-II (N = 287) than 
either the PHQ-9 (N = 155) or GDS-SF (N = 70), which may also account for some of the 
differences. A possible explanation for why participants in the current study had higher self-
reported rates of depression than previous studies is that the majority of the sample was male. 
These individuals are potentially experiencing significant life changes, both due to age and 
gender. For example, they may have been forced to recently retired, facing a different type of 
retirement than previously envisioned, or facing an early retirement due to changing abilities. 
This disruption caused by PD symptoms may pose a greater threat to a masculine self-identity 
and contribute to depression (Oliffe et al., 2013; Reitzes et al., 1996; Solimeo, 2008). 
 Stigma. In the current study, participants reported an average of 16.20 (SD=21.20, range 
0-100). This was lower than in other studies which means ranged from 34.67 to 48.13 (Jenkinson 
et al., 1995; Martinez-Martin et al., 2007; Peto et al., 2001). There are many possible reasons for 
this including this was a clinical sample from a specialized multidisciplinary PD clinic. Having 
access to the clinic and these resources may suggest a less stigmatizing environment and 
therefore the individuals feel and internalize less stigma (Ma et al., 2016). These individuals may 
also have greater support in managing their PD identities, which may protect them from feeling 
as stigmatized by it (Roger & Medved, 2010). Finally, these questions were asked within the 
context of a clinical interview, so the individuals with PD had a relationship with a provider, 
which may influence the responses they provide compared to other research methods, such as a 
mailed survey (Peto et al., 1998). 
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 Social Support. In the current study, participants reported an average score of 90.10 
(SD=17.03, range 8.33-100). This was notably higher than in other studies which means ranged 
from 24.25 to 48.99 (Jenkinson et al., 1995; Martinez-Martin et al., 2007; Peto et al., 2001). 
There are many possible explanations for this, including that this is a clinical sample which 
likely requires support/caregivers (Martínez-Martín et al., 2007). Prior relationships may be 
being redefined as individuals take on informal caregiving roles (Jeyathevan et al., 2019; 
Roberto et al., 2019). By adding a caregiving role on top of an existing relationship, this may 
increase the perception of social support in the context of the existing relationship. Furthermore, 
the questions assessing social support focused on relationship problems and lack of support from 
spouses, close relationships, family, and friends. Informal caregivers most often fall into one of 
these categories. As such, informal caregiving may be enmeshed with other social relationships 
in these responses, producing this high rate. 
 Spirituality. In the current study, participants reported an average spirituality score of 
7.77 (SD=2.02, range 0-10). Compared to a group of hospitalized depressed older adults 
responding to the same item (M = 6.57, SD = 2.61 at baseline; M = 7.86, SD = 1.76 at discharge), 
the spirituality scores were on par (Piderman et al., 2011). This may be in part because 
spirituality has been demonstrated to increase in older adulthood (MacKinlay, 2016) and has 
been shown to be a common form of coping in clinical populations (Prizer et al., 2019; Roger & 
Hatala, 2018). 
 Correlations. The results of the bivariate correlations mostly followed expected patterns. 
Specifically, motor and non-motor symptoms were highly correlated. Further, for both symptom 
types, as one experienced increasing numbers of symptoms one also experienced higher levels of 
stigma and mental health issues. This may be because as individuals have increasing symptoms, 
45 
 
they may experience greater difficulty caring for themselves and have higher levels of disability 
(Ellis et al., 2016; Rana et al., 2017). In the extant literature, both difficulty caring for oneself 
and greater disability may contribute to both higher rates of mental health issues and higher 
levels of stigma (Ma et al., 2016; Maffoni et al., 2017; Thangavelu et al., 2020). For stigma, as 
with previous literature, it was correlated with lower social support (Birtel et al., 2017; Ma et al., 
2016) and more mental health problems (Hatzenbuehler et al., 2013; Mak et al., 2007; Meyer, 
2003; Pascoe & Smart Richman, 2009).  
Social support and spirituality were each related to decreased mental health problems, 
which supports previous literature (Harris et al., 2010; Reynolds, 2017; Simpson et al., 2006; 
Takahashi et al., 2016). Among the demographics, age was associated with greater symptoms 
and more social support (Petrou, Dwamena, Foerster, MacEachern, Bohnen, Muller, et al., 2015; 
Shulman et al., 2016). While stereotypes suggest that older adults experience less social support 
(Makita et al., 2019), the evidence is mixed regarding social support and aging (Cattan et al., 
2005; Dai et al., 2016; Weiner et al., 2016). However, because of informal caregiving needs of 
this clinical PD population, this effect may be mitigated.  
Education, sex, and age correlated with many of the study variables. Education was 
associated with lower mental health problems which supports previous studies (Alegría et al., 
2000; Steele et al., 2007; Wang et al., 2000). Slight sex differences existed in the current study 
such that females reported more non-motor symptoms. In previous studies, women have reported 
greater symptoms for both physical (Lichtman et al., 2018; Styrke et al., 2013) and mental health 
conditions (Newmann, 1984; Norris et al., 2001). While there may be sex differences in the 
presentation of conditions, there are also gender-role differences in reporting and seeking help 
for health conditions (Gast & Peak, 2011; Wyke et al., 1998). Contrary to previous studies 
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(Antonucci & Akiyama, 1987; Caetano et al., 2013; White et al., 2009), males in the current 
study reported significantly higher levels of social support. However, in a previous study with a 
clinical population, males also reported higher social support (Berard et al., 2012). This suggests 
populations with chronic or major health conditions may perceive or experience social support 
differently. Additionally, in the current study, there was a greater proportion of males in the 
study sample. Another possible explanation is that the onset of PD in men is approximately 2-2.1 
years earlier than women (Gillies et al., 2014; Miller & Cronin-Golomb, 2010), which may lead 
to needing caretaking sooner or more time for adaptation of one’s social network. No sex 
differences existed in mental health problems in the current study, which is not supported in the 
literature (Clancy & Gove, 1974; de Sá Junior et al., 2019) which may in part be due to the fact 
that over half the sample was male. Interestingly, spirituality was not related to age, sex, or 
education. Previous studies have found that older adults (MacKinlay, 2016) and women (Francis 
& Wilcox, 1996; Kregting et al., 2019; Maselko & Kubzansky, 2006) are more likely to report 
spirituality. Regarding education, individuals with less formal education are more likely to 
identify as religious or religious and spiritual, with those with more formal education outpacing 
other groups as identifying themselves as “spiritual, but not religious” (Lipka & Gecewicz, 
2017). The distinction between spirituality and religiosity may have important clinical 
implications in the future. 
Mediational Analyses: Motor and Non-Motor Symptoms 
 Stigma partially mediated the relationship between both motor and non-motor symptoms 
and mental health problems. These findings are consistent with prior research that suggests that 
motor symptoms (Hermanns, 2013; Lyons et al., 1997; Maffoni et al., 2017) and non-motor 
symptoms (Hemmesch et al., 2009; Jaywant & Pell, 2010; Tickle-Degnen et al., 2011) are 
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related to stigma, and that stigma is related to mental health problems (Hatzenbuehler et al., 
2013; Mak et al., 2007; Meyer, 2003; Pascoe & Smart Richman, 2009). However, to the author’s 
knowledge, there are no other studies which have tested these relationships in a mediation. 
Moderated Mediations 
 Social support as a moderator of motor symptoms, stigma, and mental health. 
Consistent with the study hypotheses, the present study documented a moderating effect of social 
support on the relationships among motor symptoms, stigma, and mental health problems. The 
indirect effect of motor PD symptoms on mental health problems through stigma was stronger at 
lower levels of social support than at high levels, suggesting that this mediational model held 
only for those with low social support and therefore a buffering effect. This is possibly because 
individuals who have high support are shielded or better able to cope with stigma (Cadden et al., 
2018; Kondrat et al., 2018). Many individuals experience stigma as a threat, attack, or dismissal 
of an identity (Herek et al., 20090126; Howarth, 2006). Having someone—a friend, a family 
member, a significant other/partner, etc.—to talk and get advice from may allow an individual to 
process the situation and increase perceptions of available coping resources (Stevens et al., 
2013). Specifically, social support provides individuals with an outlet to gain support, insight, 
and ideas about stigmatizing encounters and to brainstorm new, effective ways of confronting 
stigma (Chronister et al., 2013; Dudley, 2000). These findings are also supported theoretically by 
the minority stress model (Meyer, 2003), which posits that distal minority stressors (e.g., stigma) 
are associated with increased mental health problems. Additionally, the impact of distal stressors 
on mental health may be mitigated by protective factors such as social support. 
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 Social support as a moderator of non-motor symptoms, stigma, and mental health. 
Consistent with the study hypotheses, there was an indirect effect in the present study which 
decreased in the hypothesized direction. However, the effect did not change between significant 
and non-significant to suggest an overall moderating effect of social support on the relationships 
among non-motor symptoms, stigma, and mental health problems. Furthermore, there was an 
interaction of stigma x social support onto mental health problems, such that the buffering effect 
was stronger for those at low levels of social support than high. Overall, those at high levels of 
social support reported lower levels of mental health problems compared to those with low social 
support. These findings are consistent with the pattern found for motor symptoms and suggest 
that whether the experience of PD stigma is being driven by motor or non-motor PD symptoms, 
social support is a potentially important protective factor.  
 Spirituality as a moderator of motor symptoms, stigma, and mental health. 
Consistent with the study hypotheses, the present study documented a moderating effect of 
spirituality on the relationships among motor symptoms, stigma, and mental health problems. 
The indirect effect of motor PD symptoms on mental health problems through stigma was 
stronger at lower levels of spirituality than at high levels, suggesting that this mediational model 
only held for those with low and mid spirituality and therefore a buffering effect. A possible 
explanation for this may be that aspects of spirituality are related to meaning making and 
purpose (Doolittle & Farrell, 2004). As individuals experience increasing symptoms, it may 
force them to confront the purpose or meaning of their illness and potentially reexamine 
fundamental beliefs about themselves and the world (Egnew, 2018; Helgeson & Zajdel, 2017; 
Shaw et al., 2005; Zeligman et al., 2018). With such a broad range of possible options imbedded 
in the single spirituality question used in the present study, individuals could easily have 
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interpreted this question to be consistent with their own form of spiritual coping (e.g., prayer, 
meditation, healing circles, etc.; Klaassen et al., 2006; Narayanasamy, 2002; Siegel & 
Schrimshaw, 2002).  
There was also a significant interaction of stigma x spirituality predicting mental health, 
such that increased spirituality reduced (buffered) the effect of stigma on mental health. Reasons 
for this may include that at low and mid-levels of spirituality, as stigma increases, individuals 
may be more prone to tap into the shame and blame narrative of chronic illness/disability (i.e., 
that their chronic illness/disability is a punishment or result of sin, or that they are being tested) 
rather than finding meaning through benevolent reframing (i.e., karma or the will of God) and to 
utilize support from a spiritual/religious community or leader (Clarke & Cardman, 2002; 
Johnstone et al., 2007; Treloar, 2002). Gall and colleagues (2005) propose a theoretical 
framework of spiritual coping. In this transactional model, individuals must appraise and 
eventually make meaning out of a stressor, which ultimately influences their well-being (i.e., 
emotional, social, physical, and spiritual). This appraisal and meaning making process is 
influenced by person factors, spiritual connections, and spiritual coping behaviors. Individuals 
low in spirituality, but with greater stigma may be making greater personal attributions related to 
their diagnosis, feel greater hopelessness about their situation, or have fewer spiritual coping 
behaviors (Gall et al., 2005). These findings are also supported theoretically by the minority 
stress model (Meyer, 2003), in which distal minority stressors (e.g., stigma) are associated with 
increased mental health problems. Furthermore, the impact of distal stressors on mental health 
may be buffered by protective factors such as spirituality. 
Spirituality as a moderator of non-motor symptoms, stigma, and mental health. 
Consistent with the study hypotheses, there was a moderating effect of spirituality on the 
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relationships among non-motor symptoms, stigma, and mental health problems. Specifically, the 
indirect effect of non-motor PD symptoms on mental health problems through stigma was 
stronger at low and mid-levels of spiritualty than at high levels, suggesting that this mediational 
model held only for those with low and mid-spirituality. The non-motor PD symptom findings 
are consistent with the pattern found for motor symptoms and similarly suggest that whether the 
experience of PD stigma is being driven by motor or non-motor PD symptoms, spirituality is a 
potentially important protective factor.  
While there was a moderating effect, there were no significant interactions such that any 
of the individual paths were moderated by spirituality. One possible explanation for this is that a 
single-item spirituality measure was used. With a single item it is not possible to measure 
internal reliability. Further a single item generally has lower sensitivity and specificity, 
suggesting a greater chance for error within this single-item measure. Finally, there is a question 
of validity; whether a single item can capture the construct. The spirituality item used was rather 
broad (i.e., regarding meaning/purpose, a higher power, etc.), which may have diffused the 
meaning. However, as motor symptoms did have significant interactions and follow-up 
regressions were also not significant, it is possible that for these individuals with PD an 
interaction effect of spirituality is not present. This may suggest more potential benefits for target 
intervention with individuals with certain motor PD symptoms—as opposed to non-motor PD 
symptoms—particularly in regard to stigma. 
 Regressions. A series of multiple hierarchal regressions showed that age and motor 
symptoms uniquely predicted stigma, motor and non-motor symptoms predicted apathy, non-
motor symptoms and age predicted anxiety, and motor symptoms, non-motor symptoms, age, 
and education predicted depression. Age and motor symptoms predicting stigma supports prior 
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research which suggests that it is the visible symptoms of PD that are most highly stigmatized 
(Hermanns, 2013; Lyons et al., 1997; Maffoni et al., 2017). Age may be operating in a two-fold 
manner in that these individuals are experiencing ageism and are more progressed in their 
disease, thus likely to have more motor (visible) symptoms (Petrou, Dwamena, Foerster, 
MacEachern, Bohnen, Muller, et al., 2015; Shulman et al., 2016).  
For apathy, being predicted by both motor and non-motor symptoms may be the result of 
the fact that goal directed, motivated behavior is more challenging in the face of greater 
symptoms (Linde et al., 2017; Massimo et al., 2018). As it becomes increasingly difficult to 
accomplish tasks, one may find it is harder to find the desire or motivation to do so. Regarding 
depression, this finding supports previous literature that has clearly established a link between 
age, education, and symptoms to depression (Brody et al., 2018; Katon & Ciechanowski, 2002; 
Mirowsky & Ross, 1992; Palinkas et al., 1990). However, this study does so specifically within 
the context of individuals with PD. 
In the current study, non-motor symptoms and anxiety were related, although, anxiety is 
often categorized as a non-motor symptom (Durcan et al., 2019; Pfeiffer, 2016). For the purpose 
of this study, non-motor symptoms included things such as “Unexpectedly fallen asleep during 
the day,” “Loss or change in your ability to taste or smell,” “Unexplained pain (not due to known 
conditions such as arthritis” or “Seeing or hearing things that you know or are told are not there.” 
For many, this loss of control (i.e., falling asleep, seeing/hearing things, and unexplained pain) 
may be very unsettling and anxiety provoking. Further, symptoms of PD are not always constant 
over time, and so individuals may be concerned about when and how bad a symptom experience 
will be (Zhu et al., 2017).  
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Potential Implications 
The findings from the current study, guided by the minority stress model, provide insight 
into the way PD symptoms are related to stigma and how that in turn influences mental health 
outcomes. Furthermore, social support and spirituality may act as protective factors to mitigate 
the relationships among PD symptoms, stigma, and mental health. From the current study, there 
is a possibility to inform future targets for clinical interventions.  
For example, as age and motor symptoms were found to uniquely predict stigma, this 
may help to identify individuals with PD who may be at greater risk for stigmatization based 
upon their clinical presentation and therefore may require targeted intervention. Additionally, as 
stigma was found to mediate the relationship between both motor and non-motor PD symptoms 
and mental health, health professionals working with individuals with PD may wish to consider 
stigma and discrimination in how they present and design treatment options for PD patients. One 
example of this may include connecting individuals with PD to support groups or mental health 
services to process experiences of PD-related stigma.  
There have been very few studies which have examined psychosocial treatments for 
apathy, anxiety, and depression among individuals with PD. Acute management of anxiety and 
depression using cognitive-behavioral therapy and other therapy modalities among individuals 
with PD have demonstrated promise, although the long-term effects of these approaches have 
had variable results (Yang et al., 2012). This may require further research to find the best 
evidence-based practice to help facilitate disability identities and increase utilization of these 
processes. 
From these results, it will also be important to consider the role of social support, as it 
was found to weaken the relationships among PD symptoms, stigma, and mental health. This 
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suggests it may be important to find ways to increase and foster social support among individuals 
with PD. In the current study, males reported higher levels of social support, which suggests it 
may be of particular importance for clinicians working with female patients (and potentially 
gender minority patients) to ensure they have access to a strong social support network. Social 
support may come from a variety of places, including informal caregivers. However, for 
individuals with PD, it may be important to have and maintain a number of positive close 
relationships (Simpson et al., 2006). Additionally, considering both the type of support 
individuals with PD receive (e.g., instrumental, emotional, and/or informational) and from whom 
the support is received (e.g., family, friends, work colleagues, or health care professionals) is 
vital, as this can have an influence on desired outcomes (Ravenek & Schneider, 2009). 
Spirituality was also found, in the current study, to weaken the relationships among PD 
symptoms, stigma, and mental health. Spiritual practices may buffer stress from chronic health 
problems and increase quality of life (Delgado, 2007). Spirituality has also been demonstrated to 
be a strong source of support for many individuals with chronic health problems (McNulty et al., 
2004; Narayanasamy, 2002). Including an assessment of spiritual practice and beliefs into patient 
assessments may help health care providers better understand an individual with PD’s 
worldview, and subsequently view of chronic illness, if there is a spiritual community of support, 
and if spiritual interventions and coping mechanisms may be appropriate and helpful for the 
individual (Nichols & Hunt, 2011). 
Limitations and Future Directions 
 The current findings and potential implications should be viewed within the context of 
the following limitations. First, this study was a secondary data analysis of PD patients from a 
multidisciplinary PD clinic at a public, academic medical center in the Mid-Atlantic region. The 
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sample was majority White, male, and had at least some college education. This sample may not 
be generalizable, given the access to the specialty clinic and demographics. Also, as the 
multidisciplinary PD clinic was located in a large urban center, this sample may not be 
representative of individuals in more rural areas or those with more limited access to care. Future 
studies may wish to collect data from a wider range of movement disorder clinics in both urban 
and rural areas to have a more representative sample. 
 Second, the data were cross-sectional. As a result, causality cannot be established 
regarding the time-ordered effect of greater PD symptoms leading to increased stigma and then 
to more mental health problems. For example, in the PDQ-39 (which was used for motor PD 
symptoms, non-motor PD symptoms, social support, and stigma) participants are asked to rate 
how often something has occurred over the previous month (Peto et al., 1998). From this it 
would not be possible to establish whether an experience of stigma occurred before or after the 
presentation of a PD symptom. Future studies may wish to employ a longitudinal study design to 
establish temporal order among the variables.  
 Third, there were several challenges in measurement that resulted from this secondary 
data analysis. As it was a secondary dataset, no additional items or measures could be included. 
In the current study, no spirituality demographic information was obtained. Future studies may 
wish to survey individuals about their spiritual/religious affiliation to see if there are differences 
across spiritual/religious orientations. There were also multiple measures for the same construct 
(i.e., depression and anxiety). These measures were scored separately according to scoring 
instructions, converted into z-scores, and then averaged. The motor and non-motor symptom 
measures were composed of items from both the PDQ-39 and NMS—both self-report 
measures—which were coded at the item level as either motor or non-motor using current PD 
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criteria of motor and non-motor symptoms and clinician review. There was only a single-item 
spirituality wellness measure. With only a single item, it is not possible to measure internal 
reliability, there is lower sensitivity and specificity, and the validity of a single item is 
questionable. Finally, the conceptualization and operationalization of stigma and social support 
on the PDQ-39 is limiting. For stigma, the questions were more inwardly focused (i.e., “Felt you 
had to conceal your Parkinson’s from people,” “Avoided situations which involve eating or 
drinking in public,” or “Felt worried by other people’s reaction to you”). The social support 
items were negatively valanced (i.e., “had problems” or “lacked support”), broad/vague (i.e., 
“support” and “problems”), and focused on a limited range of relationships (i.e., “close personal 
relationships,” “spouse or partner,” or “family or close friends”). To address some of 
measurement limitations of the present study, future studies may wish to use a physician 
symptom rating scale such as The Movement Disorder Society-Sponsored Revision of the 
Unified Parkinson’s Disease Rating Scale or the Hoehn and Yahr scale, a single mental health 
measure for each construct, and additional spirituality, stigma, and social support measures. 
Conclusions 
 The current study is among very few studies to examine the relationships among PD 
symptoms (motor and non-motor), stigma, and mental health problems among individuals with 
PD. Furthermore, it tested a mediational model linking these constructs among a clinical sample 
of PD patients. The present study also examined a potential moderating effect of social support 
and religiosity on the relationships among PD symptoms (motor and non-motor), stigma, and 
mental health problems for individuals with PD. 
For individuals with PD, social support buffered the relationships between motor 
symptoms and mental health problems and stigma and mental health problems (in both models). 
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Spirituality buffered the relationships between motor symptoms and mental health problems and 
stigma and mental health problems (for motor symptoms only). Findings from this study suggest 
that clinical intervention research with this population should focus on increasing social 
support—with attention paid to sex differences—and opportunities for spiritual engagement 
where appropriate. Furthermore, psychosocial treatments for apathy, anxiety, and depression 
among individuals with PD should be examined to find the best evidence-based practices to help 
facilitate disability identities and increase utilization of these processes. The current findings 
suggest that social support and spirituality could potentially buffer mental health problems for 
individuals with PD.  
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Appendix A 
Parkinson’s Disease Questionnaires-39 (PDQ-39) 
Due to having Parkinson’s disease, how often have you experienced the following, during the 
last month? 
  Never Occasionally Sometimes Often Always 
  0 1 2 3 4 
M 
1. Had difficulty doing the leisure 
activities you would like to do? 
0 1 2 3 4 
M 
2. Had difficulty looking after your 
home, for example, housework, 
cooking or yardwork? 
0 1 2 3 4 
M 
3. Had difficulty carrying grocery 
bags? 
0 1 2 3 4 
M 4. Had problems walking half a mile? 0 1 2 3 4 
M 
5. Had problems walking 100 yards 
(approximately 1 block)? 
0 1 2 3 4 
M 
6. Had problems getting around the 
house as easily as you would like?  
0 1 2 3 4 
M 
7. Had difficulty getting around in 
public places? 
0 1 2 3 4 
M 
8. Needed someone else to accompany 
you when you went out? 
0 1 2 3 4 
E 
9. Felt frightened or worried about 
falling in public? 
0 1 2 3 4 
M 
10. Been confined to the house more 
than you would like? 
0 1 2 3 4 
M 
11. Had difficulty showering and 
bathing? 
0 1 2 3 4 
M 12. Had difficulty dressing? 0 1 2 3 4 
M 
13. Had difficulty with buttons or 
shoelaces? 
0 1 2 3 4 
M 14. Had problems writing clearly? 0 1 2 3 4 
M 
15. Had difficulty cutting up your 
food? 
0 1 2 3 4 
M 
16. Had difficulty holding a drink 
without spilling it? 
0 1 2 3 4 
E 17. Felt depressed? 0 1 2 3 4 
E 18. Felt isolated and lonely? 0 1 2 3 4 
E 19. Felt weepy or tearful? 0 1 2 3 4 
E 20. Felt angry or bitter? 0 1 2 3 4 
E 21. Felt anxious? 0 1 2 3 4 
E 22. Felt worried about your future? 0 1 2 3 4 
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ST 
23. Felt you had to hide your 
Parkinson's from people? 
0 1 2 3 4 
ST 
24. Avoided situations which involve 
eating or drinking in public? 
0 1 2 3 4 
ST 25. Felt embarrassed in public? 0 1 2 3 4 
ST 
26. Felt worried about other people's 
reaction to you?  
0 1 2 3 4 
Ss 
27. Had problems with your close 
personal relationships? 
0 1 2 3 4 
Ss 
28. Lacked the support you needed 
from your spouse or partner?  
0 1 2 3 4 
Ss 
29. Lacked the support you needed 
from your family or close friends? 
0 1 2 3 4 
N 
30. Unexpectedly fallen asleep during 
the day? 
0 1 2 3 4 
E 
31. Had problems with your 
concentration, for example when 
reading or watching TV? 
0 1 2 3 4 
E 32. Felt your memory was failing? 0 1 2 3 4 
E 
33. Had distressing dreams or 
hallucinations? 
0 1 2 3 4 
M 34. Had difficulty speaking? 0 1 2 3 4 
N 
35. Felt unable to communicate 
effectively? 
0 1 2 3 4 
E 36. Felt ignored by people? 0 1 2 3 4 
N 
37. Had painful muscle cramps or 
spasms? 
0 1 2 3 4 
N 
38. Had aches and pains in your joints 
or body? 
0 1 2 3 4 
E 39. Felt uncomfortably hot or cold? 0 1 2 3 4 
Note: M = motor PD symptom; N = non-motor PD symptom; E = excluded; ST = Stigma 
Subscale; Ss = Social Support subscale  
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Appendix B 
Non-Motor Symptoms Questionnaire (NMS) 
The movement symptoms of Parkinson’s are well known. However, other problems can 
sometimes occur as part of the condition or its treatment. It is important that the doctor knows 
about these, particularly if they are troublesome for you. 
 
A range of problems is listed below. Please tick the box ‘Yes’ if you have experienced it during 
the past month. The doctor or nurse may ask you some questions to help decide. If you have not 
experienced the problem in the past month tick the ‘No’ box. You should answer ‘No’ even if 
you have had the problem in the past but not in the past month. 
 
Have you experienced any of the following in the last month? 
 
 
 
Yes No 
M 
1. Dribbling of saliva during the 
daytime 
Yes No 
N 
2. Loss or change in your ability to 
taste or smell 
Yes No 
M 
3. Difficulty swallowing food or drink 
or problems with choking Yes No 
N 
4. Vomiting or feelings of sickness 
(nausea) 
Yes No 
N 
5. Constipation (less than three bowel 
movements a week) or having to strain 
to pass stool (feces) 
Yes No 
N 6. Bowel (fecal) incontinence Yes No 
N 
7. Feeling that your bowel emptying is 
incomplete after having been to the 
toilet 
Yes No 
N 
8. A sense of urgency to pass urine 
makes you rush to the toilet Yes No 
N 
9. Getting up regularly at night to pass 
urine 
Yes No 
N 
10. Unexplained pains (not due to 
known conditions such as arthritis) Yes No 
N 
11. Unexplained change in weight (not 
due to change in diet) Yes No 
N 
12. Problems remembering things that 
have happened recently or forgetting to 
do things. 
Yes No 
E 
13. Loss of interest in what is 
happening around you or doing things Yes No 
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N 
14. Seeing or hearing things that you 
know or are told are not there Yes No 
N 
15. Difficulty concentrating or staying 
focused. 
Yes No 
E 16. Feeling sad, "low" or "blue" Yes No 
E 
17. Feeling anxious, frightened, or 
panicky 
Yes No 
E 
18. Feeling less interested in sex or 
more interested in sex Yes No 
E 
19. Finding it difficult to have sex 
when you try 
Yes No 
N 
20. Feeling lightheaded, dizzy or weak 
standing from sitting or lying Yes No 
M 21. Falling Yes No 
N 
22. Finding it difficult to stay awake 
during activities such as working, 
driving or eating 
Yes No 
N 
23. Difficulty getting to sleep at night 
or staying asleep at night Yes No 
N 
24. Intense, vivid dreams or frightening 
dreams 
Yes No 
N 
25. Talking or moving about in your 
sleep as if you are "acting" out a dream Yes No 
N 
26. Unpleasant sensations in your legs 
at night or while resting, and a feeling 
that you need to move 
Yes No 
N 27. Swelling of your legs Yes No 
N 28. Excessive sweating Yes No 
N 29. Double vision Yes No 
N 
30. Believing things are happening to 
you that other people say are not true Yes No 
Note: M = motor PD symptom; N = non-motor PD symptom; E = excluded 
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Appendix C 
Apathy Scale (AS) 
For each question, please place a mark in the response that best describes you. 
  
Not at 
all 
Slightly Some A lot 
0 1 2 3 
1. Are you interested in learning new things? 0 1 2 3 
2. Does anything interest you? (Excluded) 0 1 2 3 
3. Are you concerned about your condition? 0 1 2 3 
4. Do you put much effort into things? 0 1 2 3 
5. Are you always looking for something to do? 0 1 2 3 
6. Do you have plans and goals for the future? 0 1 2 3 
7. Do you have motivation? 0 1 2 3 
8. Do you have the energy for daily activities? (Excluded) 0 1 2 3 
9. Does someone have to tell you what to do each day? 0 1 2 3 
10. Are you indifferent to things? 0 1 2 3 
11. Are you unconcerned with many things? 0 1 2 3 
12. Do you need a push to get started on things? 0 1 2 3 
13. Are you neither happy nor sad, just in between? 0 1 2 3 
14. Would you consider yourself apathetic? 0 1 2 3 
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Appendix D 
Generalized Anxiety Disorder-7 (GAD-7) 
 Over the last 2 weeks, how often have you been bothered by any of the following problems? 
 
 
Not at 
all 
Several 
days 
More 
than 
half the 
days 
Nearly 
every 
day 
0 1 2 3 
1. Feeling nervous, anxious, or on edge 0 1 2 3 
2. Not being able to stop or control worrying 0 1 2 3 
3. Worrying too much about different things 0 1 2 3 
4. Trouble relaxing 0 1 2 3 
5. Being so restless that it’s hard to sit still 0 1 2 3 
6. Being easily annoyed or irritable 0 1 2 3 
7. Being afraid as if something awful might happen 0 1 2 3 
 
 If you checked off any problem on this questionnaire so far, how difficult have these problems 
made it for you to do your work, take care of things at home, or get along with other people? 
 
Not Difficult At All Somewhat Difficult Very Difficult Extremely Difficult 
0 1 2 3 
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Appendix E 
Beck Anxiety Inventory (BAI) 
Below is a list of common symptoms of anxiety. Please carefully read each item in the list. 
Indicate how much you have been bothered by that symptom during the past month, including 
today, by circling the number in the corresponding space in the column next to each symptom. 
 Not at all 
Mildly, but it 
didn't bother me 
much 
Moderately - it 
wasn't pleasant 
at times 
Severely - it 
bothered me a 
lot 
 0 1 2 3 
1. Numbness or tingling 0 1 2 3 
2. Feeling hot (Excluded) 0 1 2 3 
3. Wobbliness in legs (Excluded) 0 1 2 3 
4. Unable to relax 0 1 2 3 
5. Fear of worst happening 0 1 2 3 
6. Dizzy or lightheaded (Excluded) 0 1 2 3 
7. Heart pounding/racing 0 1 2 3 
8. Unsteady (Excluded) 0 1 2 3 
9. Terrified or afraid 0 1 2 3 
10. Nervous  0 1 2 3 
11. Feeling of choking (Excluded) 0 1 2 3 
12. Hands trembling (Excluded) 0 1 2 3 
13. Shaky/unsteady (Excluded) 0 1 2 3 
14. Fear of losing control 0 1 2 3 
15. Difficulty in breathing 0 1 2 3 
16. Fear of dying 0 1 2 3 
17. Scared 0 1 2 3 
18. Indigestion 0 1 2 3 
19. Faint/lightheaded (Excluded) 0 1 2 3 
20. Face flushed 0 1 2 3 
21. Hot/cold sweats (Excluded) 0 1 2 3 
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Appendix F 
Beck Depression Inventory (BDI) 
Below is a list of common symptoms of depression. Please carefully read each item in the list. 
Indicate how much you have been bothered by that symptom during the past month, including 
today, by circling the number in the corresponding space in the column next to each symptom. 
 0 1 2 3 
1. Sadness 0. I do not feel sad.  
 1. I feel sad much of 
the time.  
 2. I am sad all the time.  
 3. I am so 
sad or 
unhappy that 
I can't stand 
it. 
2. Pessimism 
0. I am not 
discouraged about my 
future.  
 1. I feel more 
discouraged about my 
future than I used to 
be.  
 2. I do not expect things to 
work out for me.  
 3. I feel my 
future is 
hopeless and 
will only get 
worse. 
3. Past Failure 
0. I do not feel like a 
failure.  
 1. I have failed more 
than I should have.  
 2. As I look back, I see a lot 
of failures.  
 3. I feel I am 
a total failure 
as a person. 
4. Loss of 
Pleasure 
0. I get as much 
pleasure as I ever did 
from the things I 
enjoy.  
 1. I don't enjoy things 
as much as I used to.  
 2. I get very little pleasure 
from the things I used to enjoy.  
 3. I can't get 
any pleasure 
from the 
things I used 
to enjoy. 
5. Guilty 
Feelings 
0. I don't feel 
particularly guilty.  
 1. I feel guilty over 
many things I have 
done or should have 
done.  
 2. I feel quite guilty most of 
the time.  
 3. I feel 
guilty all of 
the time. 
6. Punishment 
Feelings 
0. I don't feel I am 
being punished.  
 1. I feel I may be 
punished.  
 2. I expect to be punished.  
 3. I feel I am 
being 
punished. 
7. Self-Dislike 
0. I feel the same 
about myself as ever.  
 1. I have lost 
confidence in myself.  
 2. I am disappointed in 
myself.  
 3. I dislike 
myself. 
8. Self-
Criticalness 
0. I don't criticize or 
blame myself more 
than usual.  
 1. I am more critical 
of myself than I used 
to be.  
 2. I criticize myself for all of 
my faults.  
 3. I blame 
myself for 
everything 
bad that 
happens. 
9. Suicidal 
Thoughts or 
Wishes 
0. I don't have any 
thoughts of killing 
myself.  
 1. I have thoughts of 
killing myself, but I 
would not carry them 
out.  
 2. I would like to kill myself.  
 3. I would 
kill myself if 
I had the 
chance. 
10. Crying 
0. I don't cry any more 
than I used to.  
 1. I cry more than I 
used to.  
 2. I cry over every little thing.  
 3. I feel like 
crying, but I 
can't. 
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11. Agitation 
0. I am no more 
restless or wound up 
than usual.  
 1. I feel more restless 
or wound up than 
usual.  
 2. I am so restless or agitated 
that it's hard to stay still.  
 3. I am so 
restless or 
agitated that 
I have to 
keep moving 
or doing 
something. 
12. Loss of 
Interest 
0. I have not lost 
interest in other people 
or activities.  
 1. I am less interested 
in other people or 
things than before.  
 2. I have lost more of my 
interest in other people or 
things.  
 3. It's hard to 
get interested 
in anything. 
13. 
Indecisiveness 
0. I make decisions 
about as well as ever.  
 1. I find it more 
difficult to make 
decisions than usual.  
 2. I have much greater 
difficulty in making decisions 
than I used to.  
 3. I have 
trouble 
making any 
decisions. 
14. 
Worthlessness 
0. I do not feel I am 
worthless.  
 1. I don't consider 
myself as worthwhile 
and useful as I used 
to.  
 2. I feel more worthless as 
compared to other people.  
 3. I feel 
utterly 
worthless. 
15. Loss of 
Energy 
0. I have as much 
energy as ever.  
 1. I have less energy 
than I used to have.  
 2. I don't have enough energy 
to do very much.  
 3. I don't 
have enough 
energy to do 
anything. 
16. Changes in 
Sleeping 
Pattern 
(Excluded) 
0. I have not 
experienced any 
change in my sleeping 
pattern.  
 1. I sleep somewhat 
more than usual OR I 
sleep somewhat less 
than usual.  
 2. I sleep a lot more than usual 
OR I sleep a lot less than 
usual.  
 3. I sleep 
most of the 
day OR I 
wake up 1-2 
hours early 
and can't get 
back to sleep. 
Changes in Sleeping 
Pattern: Select the 
specific option that 
applies to you in Item 
16. (Excluded) 
0. I have not 
experienced 
any change in 
my sleeping 
pattern.  
 1. I sleep 
somewhat 
more than 
usual.  
 2. I sleep 
somewhat 
less than 
usual.  
 3. I 
sleep a 
lot 
more 
than 
usual.  
 4. I 
sleep a 
lot less 
than 
usual.  
 5. I 
sleep 
most 
of the 
day.  
 6. I wake up 
1-2 hours 
early and 
can't get back 
to sleep. 
17. Irritability 
0. I am no more irritable 
than usual.  
 1. I am more irritable 
than usual.  
 2. I am much 
more irritable 
than usual.  
 3. I am 
irritable all 
the time. 
18. Changes in Appetite 
0. I have not 
experienced any change 
in my appetite.  
 1. My appetite is 
somewhat less than 
usual OR My appetite 
is somewhat greater 
than usual.  
 2. My 
appetite is 
much less 
than before 
OR My 
appetite is 
much greater 
than usual.  
 3. I have no 
appetite at all 
OR I crave 
food all the 
time. 
Changes in 
appetite: Select the 
specific option that 
0. I have not 
experienced 
 1. My 
appetite is 
somewhat 
 2. My 
appetite is 
somewhat 
 3. My 
appetite is 
much less 
 4. My 
appetite 
is much 
 5. I have 
no 
 6. I crave 
food all the 
time. 
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applies to you in 
Item 18. 
any change in 
my appetite.  
less than 
usual.  
greater 
than usual.  
than 
before.  
greater 
than 
usual.  
appetite 
at all.  
19. Concentration 
Difficulty (Excluded) 
0. I can 
concentrate as 
well as ever.  
 1. I can't concentrate as 
well as usual.  
 2. It's hard to keep 
my mind on 
anything for very 
long.  
 3. I find I can't 
concentrate on 
anything. 
20. Tiredness or Fatigue 
0. I am no more 
tired or fatigued 
than usual.  
 1. I get more tired or 
fatigued more easily 
than usual.  
 2. I am too tired or 
fatigued to do a lot 
of the things I used 
to do.  
 3. I am too tired 
or fatigued to do 
most of the 
things I used to 
do. 
21. Loss of Interest in Sex 
(Excluded) 
0. I have not 
noticed any 
recent change 
in my interest 
in sex.  
 1. I am less interested in 
sex than I used to be.  
 2. I am much less 
interested in sex 
now.  
 3. I have lost 
interest in sex 
completely. 
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Appendix G 
Patient Health Questionnare-9 (PHQ-9) 
 Over the last 2 weeks, how often have you been bothered by any of the following problems? 
 
  
Not at 
all 
Several 
days 
More 
than 
half the 
days 
Nearly 
every 
day 
0 1 2 3 
1. Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3. Trouble falling asleep, staying asleep, or sleeping too 
much (Excluded) 
0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself, feeling that you are a failure, 
or feeling that you have let yourself or your family down 
0 1 2 3 
7. Trouble concentrating on things such as reading the 
newspaper or watching television (Excluded) 
0 1 2 3 
8. Moving or speaking so slowly that other people could 
have noticed. Or being so fidgety or restless that you have 
been moving around a lot more than usual 
0 1 2 3 
9. Thinking that you would be better off dead or that you 
want to hurt yourself in some way 
0 1 2 3 
  
 If you checked off any problem on this questionnaire so far, how difficult have these problems 
made it for you to do your work, take care of things at home, or get along with other people? 
    
Not Difficult At All Somewhat Difficult Very Difficult Extremely Difficult 
0 1 2 3 
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Appendix H 
Geriatric Depression Scale Short Form (GDS-SF) 
Choose the best answer for how you have felt over the past week: 
 Yes No 
 0 1 
1. Are you basically satisfied with your life?  0 1 
2. Have you dropped many of your activities and interests?  0 1 
3. Do you feel that your life is empty? 0 1 
4. Do you often get bored? 0 1 
5. Are you in good spirits most of the time? 0 1 
6. Are you afraid that something bad is going to happen to you 0 1 
7. Do you feel happy most of the time?  0 1 
8. Do you often feel helpless? 0 1 
9. Do you prefer to stay at home, rather than going out and doing new things?  0 1 
10. Do you feel you have more problems with memory than most? (Excluded) 0 1 
11. Do you think it is wonderful to be alive now? 0 1 
12. Do you feel pretty worthless the way you are now?  0 1 
13. Do you feel full of energy? 0 1 
14. Do you feel that your situation is hopeless? 0 1 
15. Do you think that most people are better off than you are? 0 1 
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Appendix I 
Linear Analogue Self-Assessment (LASA) 
Directions: Please circle the number (0-10) best reflecting your response to the following that 
best describes your feelings during the past week, including today. 
 
 As bad 
as it 
can be 
        As good 
as it can 
be 
 1 2 3 4 5 6 7 8 9 10 
1. How would you rate your physical well-being over 
the past week? This question refers to such things as 
fatigue, activity, etc.  
1 2 3 4 5 6 7 8 9 10 
2. How would you rate your emotional well-being over 
the past week? This question refers to such things as 
depression, anxiety, stress, etc.  
1 2 3 4 5 6 7 8 9 10 
3. How would you rate your spiritual well-being over 
the past week? This question refers to such things as 
a sense of meaning and purpose, relationship with 
God, etc. 
1 2 3 4 5 6 7 8 9 10 
4. How would you rate your intellectual well-being over 
the past week? This question refers to such things as the 
ability to think clearly, to concentrate, to remember, etc.  
1 2 3 4 5 6 7 8 9 10 
5. How would you rate your overall well-being over the 
past week?  
1 2 3 4 5 6 7 8 9 10 
Note: Bolded item (item number three) is single-item used from this scale. 
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